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ABSTRACT 
 
EXPERIENCES AND PERCEPTIONS OF RURAL POSTPARTUM WOMEN WITH 
SUBSTANCE USE DISORDERS INCLUSIVE OF OPIOIDS REGARDING THEIR 
CARE 
 
 
By 
Debra L. Kramlich 
August 2017 
 
Dissertation supervised by Rebecca Kronk, PhD, MSN, CRNP 
Perinatal opioid use and neonatal withdrawal continue to rise rapidly in the face 
of the growing epidemic of opioid addiction in the United States, with rural areas more 
severely impacted. Despite several decades of research and development of practice 
guidelines, maternal and neonatal outcomes have not improved substantially. This 
focused ethnography aimed to address that gap by exploring rural women’s experiences 
and perceptions of care to inform development of efficacious, holistic models of care to 
improve outcomes for these women and their children. Participant observations, oral 
accounts and formal interviews, and artifact review (i.e., health records, any print and 
electronic resources provided to the women to support direct care, and media 
documentation of the sociopolitical environment influencing the women’s care) were 
used to seek answers to the following questions: a) What are the experiences and 
  v 
perceptions of women with substance use disorder regarding the care they received 
during their pregnancy and through their infants’ hospitalization? and b) How have their 
experiences supported or inhibited their ability to bond with their baby? 
Thirteen participants were recruited through perinatal outpatient practices and 
hospital social workers. Their personal accounts, reinforced by participant observation 
and artifact review, uncovered three domains with underlying themes: access (service 
availability, distance/geographic location, transportation, provider 
collaboration/coordination, physical and emotional safety), care of the baby (proximity, 
information), and relationships (respect, empathy, familiarity, inclusion, interactions with 
care providers). The findings highlight the need for providers and policy makers to 
reduce barriers to care related to logistics, stigma, judgment, and lack of understanding of 
perinatal addiction. 
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CHAPTER 1 
This document is structured in accordance with the Duquesne University School of 
Nursing Manuscript Option #2 dissertation format. Chapter 1 provides an overview for this 
dissertation study, briefly summarizing the background, purpose, and specific aims, as well as 
definitions of key terms. Chapter 2 is a published systematic review. Chapter 3 is the originally 
approved proposal for the study and is written in the future tense. Chapter 4 is published 
manuscript describing methodological challenges encountered during participant recruitment for 
this study. Chapters 5 and 6 comprise the final study findings and discussion in manuscript form 
for submission for publication to Qualitative Health Research.  
Background 
The United States is facing a rapidly growing epidemic of opioid addiction. Since 1999, 
sales of prescription opioid analgesics and the rate of unintentional opioid-related overdose 
deaths have more than quadrupled, with women being affected more than men, disrupting the 
health, social, and economic welfare of the country (American Society of Addiction Medicine 
[ASAM], 2016; Senate Caucus, 2014; United States Department of Health and Human Services 
[HHS], 2016). The opioid epidemic has been accompanied by a sharp rise in perinatal exposure 
to opioids and subsequent increase in the incidence of neonatal abstinence syndrome (NAS), a 
term applied to a constellation of symptoms characterized by dysregulation and hyperirritability 
of the central and autonomic nervous, respiratory, and gastrointestinal systems (Ko et al., 2016; 
Patrick et al., 2015; Pryor et al., 2017; Tolia et al., 2015). Data show disproportionately higher 
rates of perinatal substance use in rural areas, with three states (Maine, Vermont, and West 
Virginia) experiencing greater than tenfold increases and NAS incidence rates > 30 per 1,000 
hospital births (Ko et al., 2016; Villapiano, Winkelman, Kozhimannil, Davis, & Patrick, 2016).  
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Women living in rural areas tend to have lower rates of early initiation of prenatal care, 
higher rates of pregnancy complications, and higher infant mortality rates than their urban 
counterparts, even when controlling for substance use (American College of Obstetricians and 
Gynecologists [ACOG], 2014). Additionally, socioeconomic disparities, such as poverty, 
unemployment, and low education level, which are more prevalent in rural areas, are associated 
with late or inadequate prenatal care and higher rates of adverse birth outcomes (ACOG, 2014; 
Blumenshine, Egerter, Barclay, Cubbin, & Braverman, 2010; Phillippi, 2009). Access to prenatal 
care in rural areas is often hindered by lack of resources (finances, transportation, childcare, 
availability); in women with substance use disorders, these barriers are compounded by fear of 
judgment and losing child custody (Phillippi, 2009).  
Perinatal substance use directly impacts both the woman and her offspring, and research 
over the past several decades from a variety of perspectives has attempted to identify modifiable 
factors associated with negative outcomes, with inconclusive results. Studies have failed to 
demonstrate a predictable correlation between duration, timing, and total cumulative dose of 
prescription opioids on incidence or severity of NAS; variability in presentation of NAS 
symptoms is likely multifactorial (Desai et al., 2015; Kraft, Stover, & Davis, 2016; Stover & 
Davis, 2015). Studies focusing on care of the newborn with NAS have been equally 
inconclusive. This is likely due, in part, to wide variations in care of opioid-exposed newborns 
and lack of standardized NAS treatment (Bogen, Whalen, Kair, Vining, & King, 2016; Kelly et 
al., 2016). 
A growing body of evidence is demonstrating the benefits of early and adequate prenatal 
care, harm reduction approaches, and promotion of maternal-infant bonding. Pregnancy is often 
the motivation a woman needs to seek treatment for substance use disorders, which provides an 
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opportunity for health and social care providers to engage women (Krans, Cochran, & Bogen, 
2015). Principles of harm reduction aim to ameliorate the negative impact of substance use and 
related risks, such as poverty, interpersonal violence, psychiatric comorbidity, nutritional 
deficiencies, inadequate health care, and stressful life experiences (Sutter, Gopman, & Leeman, 
2017). Such a philosophy requires care providers to set aside their own opinions and emotions 
regarding substance use and instead focus on re-engagement of the woman moving forward 
(Bartlett et al., 2013). Harm reduction approaches combined with comprehensive care models 
(antenatal care, social services, and substance use treatment) are showing promising results 
(Goodman, 2015; Marcellus, MacKinnon, Benoit, Phillips, & Stengel, 2015; Nathoo et al., 2015; 
Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, & Boyajian, 2013).  
Increased parental presence at the newborn’s bedside has been shown to increase rates of 
breastfeeding, reduce need for pharmacologic treatment, shorten duration of treatment, and 
decrease length of hospital stay (Abrahams et al., 2010; Hodgson & Abrahams, 2012; Holmes et 
al., 2016; Howard et al., 2017; Hünseler, Brückle, Roth, & Kribs, 2013; McKnight et al., 2016; 
Newman et al., 2015). Historically, opiate-exposed newborns have been admitted for 
observation, monitoring, and treatment in the neonatal intensive care unit (NICU) (Newman et 
al., 2015). This environment, while supporting medical management of newborns with NAS, can 
be stressful due to the increased stimulation and may also discourage parental presence, thus 
increasing the need for pharmacotherapy (Maguire, 2014; Newman et al., 2015). Infants may be 
safely observed and cared for in same room with their mothers; these newer rooming-in models 
can promote maternal-infant bonding and improve outcomes (McKnight et al., 2016). Variation 
in study designs and models of care, as well as the complex matrix of variables explored in those 
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studies, obscure efforts to draw conclusions with respect to best practices (Bagley, Wachman, 
Holland, & Brogly, 2014). 
Purpose 
The problems associated with perinatal substance use disorders persist despite decades of 
research. The voice of pregnant and parenting women with substance use disorders has been 
minimally included in prior studies as evidenced by the relatively limited number of qualitative 
studies. The purpose of this study was to explore rural women’s experiences and perceptions of 
care they received through their pregnancy and postpartum hospitalization, as well as 
experiences that may have influenced infant bonding.  
Study Aims 
The specific aim of the current study was to address the identified gaps in knowledge 
regarding care of this vulnerable population through the personal accounts of the women. Of 
particular interest was the role of nursing in care delivery. Ethnographic methods (Hammersley 
& Atkinson, 2007; Spradley, 1979, 1980) were used to seek answers to the following research 
questions: 
1. What are the experiences and perceptions of rural women with substance use disorder 
regarding the care they received during their pregnancy and through their infants’ 
hospitalization? 
2. How have their experiences supported or inhibited their ability to bond with their baby? 
Definitions of Key Terms 
Addiction: Various definitions of addiction are noted in the literature. Maternal addiction, in 
particular, has been defined as “a complex, progressive behavioral pattern having 
biological, psychological, medical, sociological, and behavioral components” 
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(Kaltenbach & Finnegan, 1992, p. 262). The behavioral focus of these definitions has 
perpetuated the assumption that addiction is a “moral failing or lack of individual self-
control” (Bartlett, Brown, Shattell, Wright, & Lewallen, 2013, p. 349). The American 
Society of Addiction Medicine (2015) defines addiction as “a primary, chronic disease of 
brain reward, motivation, memory, and related circuitry” (p. 3) with cycles of relapse and 
remission. This definition emphasizes the bio-psycho-social-spiritual nature of the 
disease which needs to be addressed within a multifactorial framework and will, 
therefore, be used for this study. 
Care: Defined by the mother and included, but was not limited to, access to and coordination 
and integration of services provided by nurses and other health care professionals, social 
workers, substance abuse and mental health providers, and other support agencies. 
Opioid use: Defined for the purpose of this study as use of illegal opioid drugs, such as heroin, 
misuse of legally available pain relievers such as oxycodone and hydrocodone, and/or use 
or misuse of medications prescribed for medication-assisted treatment, such as 
buprenorphine and methadone.  
Rural: The Federal Office of Rural Health Policy defines rural areas as non-Metropolitan 
(Metropolitan is defined as a core urban area of 50,000 or more population) and Rural-
Urban Commuting Area codes of 4-10 (higher numbers signify lower population density) 
(Health Resources & Services Administration, 2017).  
Substance use disorder: The recurrent use of alcohol and/or drugs which causes clinically and 
functionally significant impairment, such as health problems, disability, and failure to 
meet major responsibilities at work, school, or home. According to the DSM-5, a 
diagnosis of substance use disorder is based on evidence of impaired control, social 
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impairment, risky use, and pharmacological criteria (Substance Abuse and Mental Health 
Services Administration, 2015). 
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Relational Care for Perinatal Substance Use: A Systematic Review 
Debra Kramlich, MSN, RN, CCRN and Rebecca Kronk, PhD, MSN, CRNP 
Abstract 
Objective: The purpose of this systematic review of the literature is to highlight published 
studies of perinatal substance use disorder that address relational aspects of various care delivery 
models to identify opportunities for future studies in this area. 
Method: Quantitative, qualitative, and mixed-methods studies that included relational variables, 
such as health care provider engagement with pregnant women and facilitation of maternal-infant 
bonding, were identified using PubMed, Scopus, and EBSCO databases. Key words included 
neonatal abstinence syndrome, drug, opioid, substance, dependence, and pregnancy. 
Results: Six studies included in this review identified statistically and/or clinically significant 
positive maternal and neonatal outcomes thought to be linked to engagement in antenatal care 
and development of caring relationships with health care providers. 
Implications/Conclusion: Comprehensive, integrated multidisciplinary services for pregnant 
women with substance use disorder aimed at harm reduction show a trend toward positive 
results. Evidence exists that pregnant women’s engagement with comprehensive services 
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facilitated by caring relationships with health care providers may improve perinatal outcomes. 
Gaps in the literature remain; studies have yet to identify the relative contribution of multiple 
risk factors to adverse outcomes as well as program components most likely to improve 
outcomes. 
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Relational Care for Perinatal Substance Use: A Systematic Review 
Recently published data show a nearly threefold increase in the prevalence of perinatal 
substance use disorders (SUD) and subsequent fetal exposure to addictive substances in the 
United States in the 10-year span from 2000 to 2009, contributing to poor short-term perinatal 
and long-term developmental outcomes and creating a significant and costly public health issue 
(D'Apolito, 2009; McGlone, Mactier, & Weaver, 2009; O'Donnell et al., 2009; Patrick et al., 
2012). Women with SUD face numerous impediments to accessing available resources for 
recovery and parenting support (Fraser, Barnes, Biggs, & Kain, 2007), further complicated by 
rural healthcare disparities, specifically those related to poverty (Lander et al., 2013). Early and 
adequate prenatal care has been shown to reduce risks of prematurity and low birthweight, 
factors known to increase neonatal mortality and morbidity and often related to maternal 
substance use (Burns, Mattick, Lim, & Wallace, 2007; El-Mohandes et al., 2003; Partridge, 
Balayla, Holcroft, & Abenhaim, 2012). The level of engagement, defined in part by 
personalization of care and relationships, rather than access to services may contribute to 
improved outcomes (Docherty, Bugge, & Watterson, 2012). 
According to the World Health Organization (WHO, 2014), indigenous women such as 
Native Americans in the United States, or aboriginals in Australia or Canada, in particular, have 
been exposed to generations of emotional, psychological, and physical trauma related to 
dislocation and loss of culture, resulting in even higher rates of SUD. These women also 
experience poorer access to health care. The prevalence of unplanned pregnancies, 
unemployment, poverty, co-occurring psychiatric disorders, intimate partner violence, co-
addicted partners, history of parental abuse and addiction, and rural residence seems to be higher 
among pregnant women with SUD (Denton, Adinoff, Lewis, Walker, & Winhusen, 2014; Lander 
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et al., 2013; Unger, Metz, & Fischer, 2012). Variables such as lower socioeconomic status, rural 
isolation, poor nutritional status, environmental pollution, and domestic violence may contribute 
to negative maternal and fetal outcomes independent of substances used and irrespective of 
medication-assisted treatment (MAT) (Baldacchino, Arbuckle, Petrie, and McCowan, 2014; 
Gilligan et al., 2009; Gray, Edwards, Schultz, & Miranda, 2014; Greig, Ash, & Douiri, 2012; 
Han & Stewart, 2014; Kent, McClure, Zaitchik, & Gohlke, 2013). 
Evidence from the above-referenced studies indicates that negative perinatal outcomes 
involving substance use may be attributable to multiple and interrelated variables. Recently, the 
WHO (2014) published recommendations for care of pregnant women with SUD based on five 
overarching principles:  
 prioritizing prevention 
 ensuring access to prevention and treatment services 
 respecting patient autonomy 
 providing comprehensive care 
 safeguarding against discrimination and stigmatization  
Examples of such approaches to address this issue within a context of harm reduction, health 
promotion, and service coordination, which include the promotion of woman-health care 
provider (HCP) and mother-infant relationships, are beginning to show some promise (Benoit et 
al., 2014; Meyer et al., 2012; Wright, Schuetter, Fombonne, Stephenson, & Haning, 2012).  
Literature addressing various facets of perinatal SUD has been published in journals 
targeting distinct yet diverse audiences, such as perinatal, pediatric, substance abuse, psychology, 
and sociology practitioners, challenging widespread dissemination of study findings. Such 
diversity and the sheer volume of studies conducted over the past several decades preclude a 
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comprehensive overview of the literature. The purpose of this systematic review of the literature 
is to highlight studies of perinatal SUD that included HCP-mother-infant relational perspectives 
within various care delivery models to identify opportunities for future studies in this area as 
outlined in the WHO guidelines. 
Methods 
A systematic computer-assisted search of the English-language literature published 
within the past 10 years was conducted using keyword searches in the PubMed, Scopus, and 
EBSCO databases. Keyword search terms and Boolean combinations of neonatal abstinence 
syndrome, drug, opioid, substance, dependence, and pregnancy were used to identify relevant 
articles, including primary studies, systematic reviews, general review articles and case studies, 
and full-text dissertations and theses. Reference lists of each article were then scanned for 
additional primary sources. 
The initial search yielded 305 English-language articles published within the past 10 
years. Based on review of abstracts, 88 articles were screened for further review, yielding 38 
articles limited to quantitative, qualitative, and mixed-methods studies that included relational 
variables, such as HCP engagement with pregnant women and facilitation of maternal-infant 
bonding (see Figure 1). The articles were read in full to evaluate the extent to which relational 
variables were examined and considered important factors in outcomes. The 32 excluded articles 
focused primarily on variables such as type and amount of MAT or were secondary analyses of 
large datasets. The six studies included in this review (summarized in Table 1) identified 
statistically and clinically significant positive maternal and neonatal outcomes thought to be 
linked to engagement in antenatal care and development of caring relationships with HCP.  
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Results and Discussion 
Designs 
 Several of the studies used qualitative methods to explore women’s perspectives of the 
impact of comprehensive, integrated multidisciplinary services for pregnant women with SUD 
(Morris, Seibold, & Webber, 2012; Motz, Leslie, Pepler, Moore, & Freeman, 2006; Racine, 
Motz, Leslie, & Pepler, 2009). Motz et al. (2006) also provided quantitative results of 
retrospective clinical data collected over a 10-year span to confirm the success of the services as 
described by the women. Meyer et al. (2012) retrospectively identified their sample and analyzed 
data extracted from medical records. Buckley, Razaghi, and Haber (2013) stated their cohort was 
followed prospectively during pregnancy, yet data from hospital records were analyzed 
retrospectively. Only one of the studies followed and collected data prospectively on a cohort of 
women using objective clinical data rather than self-report (Wright et al., 2012).  
Sample Characteristics 
 Socioeconomic and demographic characteristics of the samples in the six studies are 
outlined in Table 1. Demographic data were not quantitatively reported in one study (Morris et 
al., 2012), and socioeconomic status was missing in another study (Meyer et al., 2012). Three 
samples reported indigenous status which has been found to contribute independently to 
substance use and poorer perinatal outcomes (Buckley et al., 2013; Motz et al., 2006; Racine et 
al., 2009; Wright et al., 2012). Methods of reporting pregnancy status varied from nulliparity to 
gravidity and parity means and ranges. Such disparate methods of reporting subject 
characteristics make comparisons across studies challenging.  
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Intervention/Program Characteristics 
 All six studies described some form of multidisciplinary service provision that the 
authors identified as contributing to more positive perinatal outcomes; however, the composition 
and mechanism of delivery of those services varied widely. Buckley et al. (2013) simply stated 
that a multidisciplinary team of specialist nursing and medical personnel provided 
comprehensive medical, obstetric, addiction, and psychosocial care. Meyer et al. (2012) 
described the evolution of their program from community-based services with minimal 
interaction to a multidisciplinary team that included social work, visiting nurses, physicians 
(addiction, obstetrics, and neonatology), and child protective services. These services were not 
center-based but information was freely shared among the providers. Meyer et al. (2012) state 
that services were coordinated across agencies and that most of the women and newborns 
received care within a single clinic, yet case management is not explicitly described. Neither 
program declared a particular guiding model or theoretical framework. 
 The other three programs were identified as outpatient multidisciplinary clinics with 
various service provision models. Mothercraft’s Breaking the Cycle (BTC) Pregnancy Outreach 
Program in Canada was described as a comprehensive, integrated, early intervention program 
with services delivered collaboratively through a single-access model (Motz et al., 2006; Racine 
et al., 2009). The services, many described as facilitated or provided by nurses, include 
individual and group addiction treatment, parenting programs, child care, child developmental 
services, health/medical services, mental health counseling, case management, parent-infant 
counseling, home visitation, pregnancy outreach, and support around instrumental needs such as 
food, clothing, and transportation. The Transitions Clinic (TC), located in a hospital for women 
in Melbourne, Australia, delivers comprehensive care by a multidisciplinary team, with the first 
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point of contact being two midwives (Morris et al., 2012). Antenatal and postnatal care, 
childbirth education, psychosocial and financial support, and addiction treatment is provided, 
with referral to community agencies as needed.  Both programs stage interventions according to 
the Transtheoretical Model of behavior change (TTM). They use harm reduction principles, 
which focus on ameliorating the risks associated with SUD through early engagement in prenatal 
care, encouragement of health-promoting behaviors (improved nutrition, dental care, and 
physical activity), support for reduction in use of all substances (alcohol, tobacco, and drugs), 
and promotion of social and community support. The BTC program also identified several 
theoretical frameworks as key to the success of the program: relational theory, attachment 
theory, and developmental theory. 
 These studies described integrated services for SUD and perinatal care with a particular 
focus on opioid use due to its prevalence in those populations. A comprehensive perinatal, 
addiction,  and social services clinic for pregnant women with SUD in Hawaii, also based on 
harm reduction principles, was evaluated for the impact on perinatal outcomes in pregnant 
women using methamphetamines (MA), which is particularly problematic in Hawaii and the 
western United States (Wright et al., 2012). Unlike MAT for opioid use, there are no approved 
medications for treatment of MA addiction; therefore, abstinence is the ultimate goal of therapy. 
This clinic also employed the Transtheoretical Model and Stages of Change Model. Wright et al. 
(2012) listed the services provided in this freestanding clinic but not the specific providers; 
therefore, nursing’s role in the model could not be confirmed.  
Program Outcomes  
Due to differences in definition and measurement of outcome variables, it is nearly 
impossible to compare the results of the six studies.  None of the quantitative studies shared 
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common maternal variables, and those that reported similar neonatal outcome variables used 
dissimilar measurement criteria. Pregnancy complications, such as cesarean birth, were reported 
in four of the studies (Buckley et al., 2013; Meyer et al., 2012; Motz et al., 2006; Wright et al., 
2012), but no distinctions were made between planned and unplanned cesareans nor comparisons 
made with the general obstetric population. Antenatal visits were quantified using a variety of 
methods; only one of the studies (Meyer et al., 2012) reported a statistically significant increase 
in the number of prenatal visits over the study period (p = .006), whereas the other studies only 
reported mean numbers of prenatal visits. No description of the quality of those visits was 
provided. Neonatal outcomes were typically reported as gestational age at birth, birthweight, 
incidence of neonatal abstinence syndrome requiring pharmacologic treatment, length of hospital 
stay, and discharge home with mother. The quantitative studies identified that neonatal outcomes 
were not independently related to maternal substance use. Other factors, such as treatment 
engagement and psychosocial and demographic characteristics, were predictive of improved 
outcomes. Table 1 specifically enumerates those reported outcomes. 
Perhaps the qualitative data are more indicative of positive program outcomes. Women 
engaged in comprehensive, integrated multidisciplinary programs identified the attitudes of the 
HCP and the development of collaborative relationships as essential for healing and their 
engagement in care. Morris et al. (2012) found that the initial contact between the women and 
HCP was crucial to establishment of a collaborative relationship regardless of TTM stage. 
Similarly, Motz et al. (2006) noted that respect and empathy shown by the outreach workers 
toward the women were foundational to successful relationships, which in turn fostered sustained 
positive relationships between the women and their infants, other mothers, friends, and family 
members (Racine et al., 2009). 
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Limitations 
Various models of comprehensive programs providing integrated services for SUD and 
perinatal care have been described in the literature. Differences in service structure and location, 
modes of care delivery, client demographics, and methods of program evaluation create 
challenges to comparison of outcomes as well as identification of program components that may 
have contributed to success. The programs described in this review were structured differently, 
from a monthly meeting of members of a multidisciplinary needs assessment team of community 
and hospital-based HCPs following hospitalization for initiation of treatment (Meyer et al., 
2012), to single-access community-based programs (Motz et al., 2006; Racine et al., 2009), to 
specialized multidisciplinary clinics (Buckley et al., 2013; Morris et al., 2012; Wright et al., 
2012). The composition of the multidisciplinary teams varied across the studies; one study did 
not describe specific services or HCPs (Buckley et al., 2013). Support services, such as 
transportation and child care, were provided by several of the programs (Motz et al., 2006; 
Racine et al., 2009; Wright et al., 2012), and financial incentives were explicitly described in one 
study (Wright et al., 2012). Four of the programs were located in major metropolitan areas 
(Buckley et al., 2013; Morris et al., 2012; Motz et al., 2006; Wright et al., 2012), with three 
developed in countries with universal health care (Buckley et al., 2013; Morris et al., 2012; Motz 
et al., 2006). Control groups for comparison were lacking in all the studies. 
Implications and Conclusion 
Comprehensive, integrated multidisciplinary services for pregnant women with SUD 
aimed at harm reduction are showing positive results, but gaps in the literature remain. Women 
living in remote rural geographic areas with fewer resources who may experience greater 
obstacles to accessing services are grossly underrepresented in the current studies. Research 
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regarding the impact of marijuana on maternal and neonatal outcomes is inconclusive; as more 
states legalize marijuana for recreational use, more studies will be needed to accurately inform 
practice (Miller, 2012). The recent passage of a law in Tennessee explicitly criminalizing drug 
use during pregnancy is concerning. Prior studies have demonstrated the negative impact of such 
laws related to the reluctance of women to seek treatment and prenatal care to avoid prosecution 
without the intended benefits (Lester, Andreozzi, & Appiah, 2004). This resurgence of the “War 
on Drugs” will need to be followed carefully (Lester et al., 2004, p. 3).  
Studies have yet to identify the relative contribution of multiple risk factors to adverse 
outcomes as well as program components most likely to improve outcomes. The strength of the 
evidence supporting the WHO recommendations (2014) ranges from conditional to strong, with 
the quality of the evidence rated as low to very low, indicating substantial gaps in the evidence. 
World Health Organization research priorities include improved descriptions of current practices, 
standardized outcomes and measurement of data, qualitative studies on ethical issues, and studies 
in low-income populations. The WHO recommendations offer a framework for future studies 
that may strengthen the quality evidence to support comprehensive, integrated, relationship-
based care models. 
 
Suggested Clinical Nursing Indications: 
1. Nurses caring for pregnant women with SUD should promote and facilitate 
comprehensive, integrated, multidisciplinary services to reduce barriers to care. 
2. Collaborative relationships between nurses and pregnant women with SUD, based on 
respect and empathy, can promote healing and engagement in care as well as facilitate 
mother-infant bonding. 
3. Harm reduction principles, rather than insistence on abstinence, promote understanding 
of the context of substance use and can facilitate treatment engagement and reduce 
barriers to care related to stigma and shame.  
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Suggested Websites: 
World Health Organization Guidelines for the management of substance use and substance use 
disorders in pregnancy: 
http://www.who.int/substance_abuse/activities/pregnancy_substance_use/en/ 
Substance Abuse and Mental Health Services Administration TIP 51: Substance Abuse 
Treatment: Addressing the Specific Needs of Women:  
http://store.samhsa.gov/product/TIP-51-Substance-Abuse-Treatment-Addressing-the-
Specific-Needs-of-Women/SMA14-4426 
Maine Center for Disease Control and Prevention, Snuggle ME Guidelines for Screening and 
Treatment of Pregnant Women with Substance Use Disorders: 
http://www.maine.gov/dhhs/mecdc/population-health/cshn/ 
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Table 1: Evidence for Relational Perspectives of Care Delivery for Pregnant Women  
with Substance Use Disorder 
Study Description of Study & Sample 
Characteristics 
Significant Results &  
Major Findings 
Limitations & 
Recommendations 
Buckley, 
Razaghi, 
& Haber 
(2013) 
Retrospective data analysis of a 
prospective study of pregnant 
substance-using women to 
document predictors of neonatal 
outcomes. 
Records of 183 methadone or 
heroin using pregnant women 
cared for by specialist services in 
two major teaching hospitals in 
the Sydney South West Area 
Health Services area of Australia 
(107 methadone, 15 heroin, 61 
both)  
Mean age ranged from 25.5 years 
for heroin-only users to 29 years 
for methadone-only users; 
gravidity/parity ranges were 
reported as 0-21/0-8, with means 
of 3/1 
Nearly ¼ of women were of 
indigenous origin (indigenous 
population of Australia is 2.5%); 
less than 10% were employed, 
and 85% claimed their principle 
source of income as government 
benefits or dependent on others 
No statistically significant differences 
in frequency of LBW or prematurity. 
NAS occurrence comparable across all 
groups.  
Methadone only group more likely to 
retain custody of their newborns at 
discharge (p < .001).  
Attendance at antenatal visits 
independently predicted odds of LBW, 
prematurity, and discharge status; 
therefore, engagement in antenatal care 
reduced likelihood of negative 
outcomes for the mother-infant dyad.  
Care provided by a multidisciplinary 
team thought to be crucial to treatment 
engagement. 
Data collected 
prospectively by 
clinical staff during 
routine care, then 
analyzed 
retrospectively.  
Missing data, small 
sample size, 
gestational age at 
first appointment 
not recorded.  
Need more research 
into socioeconomic 
factors, quality of 
healthcare 
interactions, and 
longer family 
follow-up.  
Meyer et 
al. (2012) 
Retrospective record review of 
women treated for opioid 
dependence during pregnancy to 
determine whether improved 
access to medication assisted 
therapy in the general population 
with improved coordination of 
ancillary services for pregnant 
women improved perinatal 
outcomes  
149 women/151 neonates 
delivered at one tertiary care 
center acting as a referral 
hospital for a rural region in 
Vermont between 2000 & 2006 
 
As access to treatment in the general 
population expanded, the # of women 
receiving treatment increased, 
proportion of women receiving interim 
substitution therapy decreased (p < 
.001), gestational age at initiation of 
treatment decreased (p < .001), & 
proportion of women receiving 
treatment before pregnancy increased 
(p < .001).  
Infants delivered to mothers in a 
treatment program had improved 
birthweight z score compared with 
those receiving interim substitution 
therapy (p = .007). % of infants 
requiring pharmacologic therapy for 
NAS decreased (p = .03).  
Transition to 
coordinated services 
occurred 
concurrently with 
expansion of MAT 
access in the general 
public.  
Unable to 
differentiate 
between impact of 
improved access to 
MAT, improved 
coordination of 
services, or effect of 
buprenorphine as an 
MAT option.  
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Mean age over the 5 data 
collection points was 24.7 to 26 
years; 5-16% were nulliparous 
(differences over the data 
collection periods not statistically 
significant) 
Demographic data regarding SES 
not reported 
Proportion of infants discharged to the 
care of the mother & remaining in 
maternal care at 1 year improved both 
over time (p = .03; p = .004) & with 
treatment within a treatment program 
(p < .001; p = .004).  
No data on women 
who left treatment 
before delivery > 
reasons for 
premature 
withdrawal.  
No data on 
polysubstance use.  
No mention of 
quality of 
relationships 
between HCP & 
pregnant women. 
Morris, 
Seibold, 
& Webber 
(2012) 
Critical ethnography to explore 
extent to which a 
multidisciplinary specialist clinic 
focused on harm minimization 
meets the needs of chemically 
dependent women. Stage of 
recovery identified according to 
the Trans-Theoretical Model 
(TTM) 
20 chemically dependent 
pregnant women at a major 
metropolitan women’s hospital in 
Australia 
Demographic data not 
quantitatively reported; women 
described as experiencing family 
instability, family history of drug 
& alcohol abuse, childhood 
sexual abuse, chemically 
dependent partners, and dual 
diagnoses of addiction & mental 
illness. 
Multiple factors influence development 
& maintenance of chemical 
dependency: family instability, family 
history of drug & alcohol abuse, 
childhood sexual abuse, having a 
chemically dependent partner, dual 
diagnosis of substance use and mental 
illness.  
Attitudes of individual staff members, 
particularly midwives, were key to the 
way women responded to care and the 
evolution of collaborative relationships 
between HCP & pregnant women.  
Initial contact between women & HCP 
crucial to establishment of relationship 
regardless of TTM stage.  
Women sometimes felt secondary to 
unborn child & resented being seen as 
“baby incubators”.  
Women felt discounted in decision-
making.  
Physical space not facilitative of 
communication.  
Supportive relationships developed 
over time; most participants (15/20) 
reported positive benefits & desire to 
maintain engagement with the clinic 
program.  
Some services felt to 
be lacking: family 
therapists trained in 
mental health with 
drug & alcohol 
qualifications, and 
postnatal support for 
women able to 
parent children.   
Need quantitative 
studies to examine 
perinatal outcomes 
related to 
engagement in such 
care. 
Motz et 
al. (2006) 
Part 3 of this comprehensive 
report describes the evaluation of 
the Breaking the Cycle (BTC) 
program in Toronto, Canada, 
Statistical significance of outcomes 
was not reported; trends toward 
improvement in numerous perinatal 
health indicators and outcomes  noted 
Limitations: self-
report, limited 
objective substance 
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using quantitative & qualitative 
methods.  
BTC is a comprehensive, 
integrated, single-access early 
intervention program for 
pregnant women with substance 
use disorders based on principles 
of harm reduction, relational 
theory, developmental theory, 
and attachment theory.  
Approaches & interventions used 
TTM/Stages of Change model & 
Motivational Interviewing (MI) 
Data collected from 160 high-
risk women engaged in the BTC 
Pregnancy Outreach Program 
(CPNC) April 2001-May 2005; 
data collected on 1170 mothers 
accessing BTC 1995-2005 
Mean age 28 years; average of 
one prior pregnancy (range 0-10) 
Sociodemographic characteristics 
of participants extensively 
described: briefly, 13% identified 
as indigenous (as compared with 
4.3% of the general population); 
46% experienced homelessness; 
37% had no income & 49% were 
receiving general public 
assistance; significantly higher 
rates of food insecurity; 70% had 
≤ 10 years of schooling; 60% 
were single.  
when the Pregnancy Outreach Program 
was added, including:   
 Lower gestational  age at 
initial engagement in care 
 Greater access to & use of 
supportive health & treatment 
services 
 More likely to complete 
treatment 
 Retained custody of children 
 Maintained  substance use 
recovery at discharge 
 Greater maternal-infant 
attachment 
 More normal child 
development 
 
Respect & empathy shown by 
Pregnancy Outreach Worker (POW) 
foundational to successful 
relationships. 
use data, no control 
group.  
 
  
Racine et 
al. (2009) 
Qualitative study to describe 
experiences of pregnant 
substance-involved women 
engaged in a comprehensive, 
integrated, single-access early 
intervention program (Breaking 
the Cycle Pregnancy Outreach 
Program - CPNC) based on 
principles of harm reduction, 
relational theory, developmental 
theory, and attachment theory. 
 
Promotion of relational capacity in 
pregnant & parenting women involved 
with substance use; non-judgmental, 
caring attitudes & behaviors of 
outreach workers; being with other 
similar women; healing through the 
power of relationship. 
Rich data gleaned from the stories of 
the women engaged in this outreach 
See above; this 
study gleaned 
qualitative data 
regarding aspects of 
the program likely 
to engage and retain 
women in the 
program. 
Quantitative studies 
with control groups 
in similar 
populations would 
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Three focus groups with total n = 
19 former high-risk clients of the 
BTC CPNC program in Toronto, 
Canada (demographics described 
above in Motz et al. study); a 
subset of a larger mixed-methods 
program evaluation study 
comparing BTC with CNPC 
 
strengthen the 
findings 
Wright et 
al. (2012) 
Examine outcomes of 
implementation of a harm-
reduction model for clinical care 
of substance using pregnant 
women; used Stages of Change 
Model & MI 
132 pregnant women (47% 
indigenous) with past or present 
history of addiction cared for in a 
clinic offering comprehensive 
perinatal & social services in an 
urban, academic medical center 
Hawaii, compared with a 
representative cohort of women 
(22% indigenous) delivering at 
the same hospital without the 
clinic services. 
Mean age 28.3 years; gravidity 
4.5/parity 2.3 
Statistically significantly higher rates 
of gravidity & parity, smoking & 
methamphetamine use, chronic 
medical conditions & native Hawaiian 
in clinic cohort (all p < .001); no 
statistically significant differences in 
pregnancy complications. Predictors of 
poor infant outcomes were related to 
factors other than drug use (parity, 
history of domestic violence, maternal 
medical conditions, poor prenatal 
care). 
Assumed that comprehensive care 
delivered using harm-reduction 
approaches & motivational incentives 
resulted in relatively normal birth 
outcomes. 
No control group of 
substance-using 
pregnant women not 
engaged in 
comprehensive 
services for 
comparison. 
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Figure 1: Flow diagram of article selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting 
 Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097 
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synthesis 
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CHAPTER 3 
Chapter 3 is the dissertation proposal in its original form, presented on November 13, 2014. 
 
Experiences and Perceptions of Postpartum Women with Substance Use Disorders Inclusive of 
Opioids Regarding Their Care 
Specific Aims 
Data show a rapidly increasing prevalence of substance use disorders during pregnancy 
and subsequent perinatal exposure to addictive substances, resulting in poor short-term fetal and 
neonatal and long-term developmental outcomes and creating a significant and costly public 
health issue worldwide  (D'Apolito, 2009; McGlone, Mactier, & Weaver, 2009; O'Donnell et al., 
2009; Patrick et al., 2012). Excessive prenatal substance exposure may result in negative birth 
outcomes, including low birthweight and prematurity, and cause neonatal abstinence syndrome 
in infants, including respiratory problems, feeding difficulties, and seizures (Walton-Moss, 
McIntosh, Conrad, & Kiefer, 2009). More is becoming known about the long-term effects of 
drug exposure, including delayed cognitive and motor development (Mactier, 2013) and 
increased child protective involvement (Lean, Pritchard, & Woodward, 2013), placing an even 
greater burden on health care, social welfare, and foster care services. 
Maine has the highest rate of prescription opiate drug misuse in the country (Hayes & 
Brown, 2012); a report published in 2010 by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) noted Maine’s per capita rate of non-heroin opiate addiction in 2008 
was 386 per 100,000, compared to 45 per 100,000 for the Unites States and 131 for New 
England. The percentage of newborns with neonatal abstinence syndrome discharged from 
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Maine hospitals rose from 0.1% in 2000 to 2% in 2009  and those numbers continue to increase; 
927 babies were born affected by drugs in Maine in 2013, more than 7% of all births (Maine 
DHHS, 2014). Despite increasing attention on this problem and evidence-based 
recommendations (Dow et al., 2012; Goettler & Tschudin, 2014; Hudak & Tan, 2012; Jansson, 
Velez, & Harrow, 2009; Lucas & Knobel, 2012; Queensland & Neonatal Clinical Guidelines, 
2010; Winklbaur et al., 2008), management remains inconsistent, hospital length of stay has not 
declined, and expenditures continue to rise. Quantitative and interventional studies have yet to 
produce sustained, efficacious improvement in outcomes for these mothers and children 
(Milligan et al., 2010). Additionally, societal stigma and lack of resources further contribute to 
the negative outcomes for both mother and child (Lander et al., 2013).  
Women with substance use disorders continue to face numerous impediments to 
accessing available resources for recovery and parenting support (Fraser, Barnes, Biggs, & Kain, 
2007). Substance use disorder in women is associated with increased prevalence of mental 
illness, histories of physical and sexual abuse, and medical and social problems (Milligan et al., 
2010). Studies have shown that rural healthcare disparities, specifically those related to poverty, 
further complicate access to treatment (Lander et al., 2013). This is particularly concerning in 
light of findings that protective factors, such as caretaker involvement and family resources, may 
moderate the negative effects of substance use on the developing child (Bada et al., 2012). An 
exploration of the experiences of women with substance use disorder regarding the care they 
have received for pregnancy, parenting, recovery, and psychosocial and economic issues is 
necessary to identify unmet needs and determinants of the problem. Since many of the studies 
described in the background and significance of the problem have focused on the perinatal 
impact of opioid use, the population of interest in the proposed study is defined as women with 
  36 
any form of current opioid use (illicit, misuse of prescription opioid medications, medication 
assisted treatment) and not excluding use of other substances. The long-term objective, future 
development of efficacious interventions to promote successful parenting and decrease the risk 
of further trauma to the mother-infant dyad, is contingent upon such understanding.  
The specific aim of this study is to begin to bridge the current gap in knowledge 
regarding care of this vulnerable population. “Care” will be defined by the mother and may 
include, but not be limited to, access to and coordination and integration of services provided by 
nurses and other health care professionals, social workers, substance abuse and mental health 
providers, and other support agencies. Of particular interest will be the role of nursing in care 
delivery. This may be achieved through a qualitative exploration of the following questions: 
1. What are the experiences and perceptions of women with substance use disorder, defined 
for the purpose of this study as any form of current opioid use while not precluding use of 
other substances, regarding the care they received during their pregnancy and through 
their infants’ hospitalization? 
2. How have their experiences supported or inhibited their ability to bond with their baby? 
Background and Significance 
Results from the 2013 National Survey on Drug Use and Health found that among 
pregnant women aged 15 to 44, 5.4% were current illicit drug users (SAMHSA, 2014). Current 
illicit drug use was lower among pregnant women aged 15 to 44 during the third trimester than 
during the first and second trimesters (2.4% vs. 9.0% and 4.8%). When stratified by age, the rate 
of current illicit drug use was 14.6% among pregnant women aged 15 to 17, 8.6% among women 
aged 18 to 25, and 3.2% among women aged 26 to 44. According to data from the Treatment 
Episode Data Set (TEDS), while the proportion of substance abuse treatment admissions in 
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females aged 15 to 44 years who were pregnant at treatment entry has remained stable between 
2000 and 2010, the percentage reporting drug abuse but not alcohol abuse has increased from 
51.1% to 63.8% (SAMHSA, 2013).  
Of drug exposed newborns, 50% to 90%  will experience some degree of neonatal 
abstinence syndrome, a term applied to a constellation of symptoms characterized by 
dysregulation and hyperirritability of the central and autonomic nervous, respiratory, and 
gastrointestinal systems (Sublett, 2013). Symptoms are treated with a combination of 
pharmacologic and non-pharmacologic therapies typically requiring specialized care in the 
neonatal intensive care unit (NICU) with an average length of hospital stay of 25 days.   
A retrospective study conducted by Patrick et al. (2012) found that between 2000 and 
2009 the incidence of neonatal abstinence syndrome among newborns in the U.S. increased from 
1.20 to 3.39 per 1000 hospital births per year while antepartum maternal opiate use increased 
from 1.19 to 5.63 per 1000 hospital births per year. In 2009, newborns with neonatal abstinence 
syndrome were more likely than all other hospital births to have low birthweight, have 
respiratory complications, and be covered by Medicaid. Mean hospital charges for discharges 
with neonatal abstinence syndrome increased from $39,400 in 2000 to $53,400 in 2009. By 
2009, 77.6% of charges for neonatal abstinence syndrome were attributed to state Medicaid 
programs (Patrick et al., 2012). 
Concerns regarding perinatal substance use are not new; literature regarding physician 
interest in the effects of drugs and alcohol on women and children dates back nearly three 
centuries (Boyd & Marcellus, 2007). Attitudes toward therapeutic and illicit use of substances, 
particularly opioids, and approaches to addiction treatment have been shaped by various social, 
moral, political, economic, and legal influences. The development of practices and policies 
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specifically addressing perinatal substance use has paralleled the evolution of the rights of 
women and children, including the unborn fetus. Generally, the women affected by such 
decisions have been excluded in the process. 
Pregnant and parenting women with substance use disorders present a particular 
challenge with regard to problem identification and outcome measurement. Pregnancy and 
childbirth are considered normal physiological processes, yet framed by the disease of addiction, 
these processes tend to be pathologized and used to punish women for their addictive behaviors 
(Boyd & Marcellus, 2007). Salmon (2010) advanced the term reproductive citizenship to 
describe the assumption that women have both the ability and responsibility to minimize risk in 
their lives during pregnancy and birth. Pregnant and parenting women who use substances have 
been thought to be deviant; such moral judgments, stigmatization, and subsequent punitive 
policies have resulted in challenges to engagement of these women in the treatment process. 
The disease of addiction, particularly maternal addiction, has been defined as “a complex, 
progressive behavioral pattern having biological, psychological, medical, sociological, and 
behavioral components” (Kaltenbach & Finnegan, 1992, p. 262) and, therefore, needs to be 
addressed within a multifactorial framework. Maternal substance use disorder does not occur in a 
vacuum, and it would be a disservice to describe and explain addictive behaviors solely on the 
basis of individual factors. One study found multiple biopsychosocial predictors of treatment 
outcomes in women with substance use disorders and identified the importance of careful 
assessment of these factors when designing outpatient and residential treatment programs for 
these women (Comfort, Sockloff, Loverro, & Kaltenbach, 2003). As noted by Suchman, Pajulo, 
and Mayes, (2013), “pregnant and parenting women who suffer from substance use disorders 
present a very complex and difficult challenge to those concerned with improving the 
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environment of care for their children” (p. 185). These women often report family histories of 
substance abuse which suggests both genetic and environmental determinants of substance 
misuse. They also experience higher rates of violence, trauma, and subsequent post-traumatic 
stress disorder, as well as psychiatric comorbidity. Native American women, in particular, have 
been exposed to generations of emotional, psychological, and physical trauma related to 
dislocation and loss of culture, resulting in even higher rates of substance use disorder (Bohn, 
2003; SAMHSA, n.d.). The lack of positive role models and personal coping skills further 
contribute to substance use disorders in women with these multiple, complex challenges. It 
seems a majority of the published studies of antenatal substance use disorders and the impact on 
the women and infants have failed to account for this complexity and have targeted limited 
aspects of the problem.    
Maternal Medication-Assisted Treatment and Neonatal Outcomes 
Perinatal substance use directly impacts two constituencies, the woman and her offspring, 
and therefore the problem has been examined from a variety of perspectives. Numerous 
quantitative studies have been conducted to identify factors regarding maternal drug use which 
may be predictive of neonatal outcomes, such as the type and amount of medication-assisted 
treatment for opioid use. Several retrospective studies associated higher doses of maternal 
methadone dose with higher incidence of neonatal abstinence syndrome as well as duration of 
neonatal abstinence syndrome treatment (Dryden, Young, Hepburn, & Mactier, 2009; Lim, 
Prasad, Samuels, Gardner, & Cordero, 2009). These findings contradicted those of other studies, 
which reported no such correlation (Berghella et al., 2003; McCarthy, Leamon, Parr, & Anania, 
2005; Pizarro et al., 2011; Seligman et al., 2008). One prospective cohort study also concluded 
that the incidence and duration of neonatal abstinence syndrome was not affected by methadone 
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dose (Cleary et al., 2012). McCarthy, Leamon, Stenson, and Biles (2008) noted that infants of 
women who began methadone treatment prior to conception had better outcomes compared with 
those whose mothers began treatment mid-pregnancy.  
Similar conflicting results have been noted in studies comparing maternal methadone and 
buprenorphine medication-assisted treatment. Several studies suggested improved neonatal 
outcomes, such as lower incidence and severity of neonatal abstinence syndrome, in infants 
exposed to buprenorphine as compared with methadone exposure (Binder & Vavrinkova, 2008; 
Coyle et al., 2012; Gaalema et al., 2012; Kakko, Heilig, & Sarman, 2008; Salisbury et al., 2012). 
Other studies found no such differences (Jones et al., 2010; Lejeune, Simmat-Durand, Gourarier, 
& Aubisson, 2006; Welle-Strand et al., 2013). Patel and colleagues (2013) noted no difference in 
neonatal abstinence syndrome expression when comparing infants exposed to buprenorphine to 
those exposed to illicit opiates. The concomitant use of illicit substance, as well as alcohol and 
tobacco, with medication-assisted treatment seems to confound the results of these studies 
(Blandthorn, Forster, & Love, 2011; Kaltenbach et al., 2012). 
Many of the aforementioned studies have been retrospective reviews of clinical data or 
secondary analyses of data from larger studies. Two multicenter prospective studies from which 
much data have been drawn, the Maternal Lifestyle Study (Bauer et al., 2002) and the Maternal 
Opioid Treatment: Human Experimental Research (MOTHER) study (Jones et al., 2010), have 
generated a great deal of discussion and debate among the scientific and practice communities. 
Findings of these studies regarding severity of neonatal abstinence syndrome relative to type and 
dose of maternal substance or medication-assisted treatment have been conflicting. In fact, 
Winklbaur-Hausknost and colleagues (2013) found that maternal treatment resulting in reduced 
illicit drug use throughout pregnancy had no influence on neonatal outcomes in two separate 
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studies. In a systematic review and meta-analysis, Cleary and colleagues (2010) found no clear 
link between neonatal abstinence syndrome severity and methadone dose. Similarly, Thajam, 
Atkinson, Sibley, and Lavender (2010) found no correlation between amount and type of fetal 
opioid exposure and neonatal abstinence syndrome expression in eight of the 10 studies they 
reviewed. It may be concluded that a singular focus on drug type and dose fails to account for the 
complex array of factors contributing to neonatal outcomes. 
Maternal-Infant Bonding 
Literature regarding neonatal abstinence syndrome care has been equally inconclusive. 
Sublett (2013) noted that, despite extensive research on pharmacologic therapy and 
recommendations by the American Academy of Pediatrics, no clear answer to standardized 
neonatal abstinence syndrome treatment has been established. This is likely due, in part, to 
failure to establish a definite relationship between maternal drug type and dose and severity of 
neonatal withdrawal symptoms (Dryden et al., 2009; Sublett, 2013; Velez, Jansson, Schroeder, & 
Williams, 2009). It appears that factors other than maternal medication-assisted treatment, such 
as maternal-infant bonding, have greater influence on neonatal outcomes. One study conducted 
by Saiki, Lee, Hannam, and Greenough (2010) showed that care of neonatal abstinence 
syndrome infants on the postpartum unit with their mothers, rather than in the NICU, resulted in 
shorter duration of treatment and hospital stay.  
Backes and colleagues (2012) found that infants discharged home on a methadone 
weaning protocol with support from a multidisciplinary team, as opposed to a traditional 
inpatient methadone wean, resulted in shorter hospital stays and reduced cost. A retrospective 
review conducted in the United Kingdom yielded similar findings (Smirk, Bowman, Doyle, & 
Kamlin, 2014). Investigators in both studies noted that breastfeeding rates were significantly 
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higher in the home detoxification groups which may have accounted for perceived benefits. 
Several studies found that substantial breast milk intake significantly reduced severity of 
neonatal abstinence syndrome symptoms, delayed the onset of symptoms, and decreased the 
need for pharmacologic treatment (Abdel-Latif et al., 2006; Dryden et al., 2009). These studies 
seem to support the conclusion that treatment of the neonatal abstinence syndrome baby should 
be provided with the participation of the mother to promote maternal-infant bonding and 
breastfeeding (Sublett, 2013). As will be noted, however, engagement of the mothers to establish 
a foundation for this bonding has proven challenging. 
Maternal Substance Use and Child Maltreatment 
According to Smarsh Hogan and Myers (2006), it is commonly believed that mothers 
with substance use disorders may place their children at higher risk of maltreatment. While data 
suggest an association between maternal substance use disorders and child maltreatment (Walsh, 
MacMillan, & Jamieson, 2003), other studies have noted that environmental risks, such as 
depression, psychiatric disorders, domestic violence, and lower socioeconomic status may 
contribute more significantly to child maltreatment (Nair, Schuler, Black, Kettinger, & 
Harrington, 2003; Smarsh Hogan & Myers, 2006). Unfortunately, pregnant women with 
substance use disorders tend to face those same problems; studies have shown a higher 
prevalence of unplanned pregnancies, unemployment, poverty, co-occurring psychiatric 
disorders, intimate partner violence, co-addicted partners, history of parental abuse and 
addiction, and rural residence among this population (Denton, Adinoff, Lewis, Walker, & 
Winhusen, 2014; Lander et al., 2013; Unger, Metz, & Fischer, 2012). 
Early Identification, Engagement, and Treatment Retention 
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Early and adequate prenatal care has been shown to mitigate the negative effects of 
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning, 
2012). Unfortunately, pregnant women with substance use disorders may delay or completely 
avoid seeking care due to fears of judgmental or uncivil care provider reactions (Metz, Kochl, & 
Fischer, 2012). These fears are not unfounded; evidence has shown continued misunderstanding 
and negative attitudes of healthcare providers toward pregnant women with substance use 
disorders (Benoit et al., 2014; Fraser et al., 2007; Maguire et al., 2012; Murphy-Oikonen, 
Brownlee, Montelpare, & Gerlach, 2010). Socioeconomic constraints and low literacy levels are 
additional barriers to treatment engagement (Alto & O'Connor, 2011). While attrition rates for 
women who do engage in treatment are reported to be high (Sharon M. Mullins, Suarez, 
Ondersma, & Page, 2004), engagement is the first step toward treatment and recovery. Ideally, 
comprehensive care for these women would include treatment for the substance use to promote 
abstinence and ease withdrawal symptoms, combined with antenatal care and social services to 
support parenting success. Pregnancy is often the impetus a woman needs to seek treatment for 
substance use disorder, providing an opportunity for health and social care providers to engage 
these women. 
Studies of early identification, engagement, and treatment retention of pregnant women 
using integrated substance abuse and perinatal services are showing potential benefits in the 
promotion of maternal-infant bonding (Burns, Mattick, Lim, & Wallace, 2007; Kissin, Svikis, 
Moylan, Haug, & Stitzer, 2004; Mayet, Groshkova, Morgan, MacCormack, & Strang, 2008; 
Meyer et al., 2012; Mullins, Bard, & Ondersma, 2005; Racine, Motz, Leslie, & Pepler, 2009; 
Suchman, Mayes, Conti, Slade, & Rounsaville, 2004; Suchman, Pajulo, DeCoste, & Mayes, 
2006; Taylor et al., 2012). Identification of maternal substance use has been challenging. Some 
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studies have indicated that universal screening of all women for drugs and alcohol may reduce 
socioeconomic and racial disparities, resulting in improved identification (Casper & Arbour, 
2013; Eichel & Johannemann, 2014; Roberts & Nuru-Jeter, 2011). Others have questioned the 
wisdom of this approach, suggesting that fear of negative consequences may preclude women 
from seeking prenatal care (Roberts & Nuru-Jeter, 2010). 
A variety of strategies for engagement of pregnant women with substance use disorders 
in prenatal care and treatment have been explored. Motivational interviewing (MI) and 
motivational enhancement therapy (MET) have been included in studies of prenatal alcohol use 
(Osterman & Dyehouse, 2012), treatment utilization in pregnant substance users (Winhusen et 
al., 2008), and treatment retention of women with substance use disorders involved with child 
welfare (Mullins et al., 2004). Both MI and MET interventions have shown mixed results in 
pregnant women. According to Jones and Kaltenbach (2013), MI appears to hold some promise 
as part of a comprehensive approach, but more studies are needed to determine if and how it 
facilitates behavior change in this population. 
Use of behavioral incentives has been explored as a means for engaging and retaining 
pregnant women in substance-abuse treatment (Brigham, Winhusen, Lewis, & Kropp, 2010; 
Comfort, Loverro, & Kaltenbach, 2000; Hutchinson, Chisholm, Tuten, Leoutsakos, & Jones, 
2012; Jones, Svikis, Rosado, Tuten, & Kulstad, 2004; Schottenfeld, Moore, & Pantalon, 2011; 
Svikis, Silverman, Haug, Stitzer, & Keyser-Marcus, 2007). Results have been mixed, but it 
seems that efficacy is related to the type, amount, timing, and frequency of the incentives as well 
as the mechanism of treatment entry (coerced versus voluntary). Trust-building was also found to 
be an important component of the intervention. 
Harm-Reduction Philosophy  
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Decades of failed attempts to require and achieve abstinence in addictive behaviors has 
led to development of a harm-reduction philosophy (Boyd & Marcellus, 2007). Harm-reduction 
recognizes the relapsing characteristic of substance-misuse, not unlike other chronic diseases, 
and is “based on the premise that alcohol and drug addiction and the associated risks can be 
placed on a continuum, with the goal being to help the client move along this continuum from 
excess to moderation” (Suchman et al., 2013, p. 375). Such a philosophy requires care providers 
to set aside their own opinions and emotions regarding relapse and instead focus on re-
engagement of the woman moving forward. Studies of harm-reduction approaches in Britain, the 
Netherlands, and Canada have shown positive outcomes in terms of lower rates of child 
protective involvement and withdrawal symptoms in infants (Boyd & Marcellus, 2007). Pilot 
studies in the U.S. have shown similar results (Wright et al., 2012). The programs described in 
the literature have used a variety of interventions, including integrated prenatal and substance 
abuse services and motivational incentives, so it is unclear which aspects of a harm-reduction 
approach contribute to outcomes.  
Literature Synthesis and Identified Gap 
As the literature shows, the problem of maternal substance use and its negative impact on 
both the mother and the infant persists despite numerous quantitative studies from multiple 
perspectives. Recent studies continue to demonstrate a lack of provider understanding of the 
disease of maternal addiction (Benoit et al., 2014). It would seem from this review of the 
literature that the voice of pregnant and parenting women with substance use disorders has been 
minimally included in prior studies as evidenced by the relatively limited number of qualitative 
studies. A more focused review of the literature, highlighting studies of perinatal substance use 
disorders that included health care provider-mother-infant relational perspectives within various 
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care delivery models, was conducted by this researcher and submitted for publication (Chapter 
2). Published studies have yet to identify the relative contribution of multiple risk factors to 
adverse outcomes as well as program components most likely to improve outcomes. The 
proposed study aims to address that gap by exploring the women’s experiences and perceptions 
of care. Nurses and other health care professionals may then be better able to provide efficacious, 
holistic care to improve outcomes for these women and their children. 
Preliminary Work 
 Preliminary explorations have provided background information to guide this study. 
Telephone conversations and personal meetings with various providers of care for these women 
as well as attendance at conferences and meetings where these individuals have spoken have 
contributed to a greater awareness of the problem. These care providers identified potential sites 
for observation and processes for gaining access to informants in addition to anticipated 
challenges. The relationships cultivated with these professionals will enhance this researcher’s 
ability to conduct the proposed study. This pre-fieldwork yielded what Hammersley and 
Atkinson (2007) termed a foreshadowed problem, the starting point for an investigation that will 
evolve as knowledge is gained through inquiry and observation. 
Research Design and Methods 
Research Design 
 In the proposed study, ethnographic methods (Hammersley & Atkinson, 2007; Spradley, 
1979, 1980) will be used to better understand: (1) the experiences and perceptions of postpartum 
women with substance use disorders regarding the care they received during their pregnancy and 
through their infants’ hospitalization; and (2) how have their experiences supported or inhibited 
their ability to bond with their baby. These methods will include: participant observation of 
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postpartum women with substance use disorders at Eastern Maine Medical Center; oral accounts 
and formal interviews; and artifact review, such health records and print and electronic resources 
provided to the women to support direct care.  
Ethnographic studies are designed to understand a culture by learning from the people 
within that culture through contextualized examination of their speech, behavior, and artifacts 
(Spradley, 1979). A focused ethnography, defined by Munhall (2012) as “the study of small 
elements of one society, group, or culture; focus on [a] distinct problem within a specific context 
among a small group of people” (p. 291) is particularly suitable for the proposed study. The 
topics of inquiry for a focused ethnography are pre-selected, and the short-term yet time-
intensive nature of observations are conducive to the study of sensitive topics and complex issues 
such as substance use disorders in women during the postpartum period within the limitations 
imposed by dissertation studies.  
The exploratory nature of ethnographic research requires a focused yet flexible approach 
to sampling and data gathering and analysis (Maxwell, 2013). The anticipated population and 
study methods described as follows are tentative; the design will emerge as the study progresses.  
Setting 
 This study will be conducted at Eastern Maine Medical Center in Bangor, Maine, which 
serves Washington and Penobscot Counties in northern Maine. According to the Maine Office of 
Substance Abuse and Mental Health Services (2012) these counties have the highest rates of 
opiate addiction in Maine. The 927 drug-affected births reported in Maine in 2013 represent 
about 7% of live births (Maine DHHS, 2014). At Eastern Maine Medical Center there were 308 
substance-exposed infant reports in 2011, approximately 19% of live births at Eastern Maine 
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Medical Center that year; nearly 60% of the mothers of those infants lived in Washington or 
Penobscot counties.  
Poverty, rural isolation, and Native American culture have been noted to contribute to 
poor perinatal outcomes and challenges to access to care (Bohn, 2003; Kent, McClure, Zaitchik, 
& Gohlke, 2013). Penobscot and Washington Counties have the highest rates of poverty (Maine 
State Planning Office, 2012) and lowest population density in the state (Maine DHHS, 2008). 
Nearly 20% of the total population of Washington County is reported to live below the poverty 
level; the highest rate of child poverty (nearly 31%) is in Washington County. Maine is one of 
the least densely populated states in the country, and both counties include a large number of 
unorganized territories (an area having no local, incorporated municipal government). While less 
than 1% of the population (0.9% U.S., 0.6% Maine) is identified as Native American, 4.9% of 
the population of Washington County is identified as such (Maine CDC, 2103). All of which 
underscore the importance of research in this setting.  
The majority of pregnant women with substance use disorders in both counties deliver 
their babies at Eastern Maine Medical Center (located in Bangor in Penobscot County), the 
state’s second largest hospital which serves the northern two-thirds of the state and delivers an 
average of 1,600 babies annually. This encompasses a relatively large geographic area, with 
towns located in the farthest reaches of Washington and Penobscot Counties situated over 100 
miles from the hospital. Three smaller hospitals located 50 to 100 miles from Bangor provide 
obstetric services but do not provide care for newborns with neonatal abstinence syndrome 
requiring treatment. Newborns delivered at one of those small hospitals, either anticipated or 
unplanned, who show signs of neonatal abstinence syndrome in need of treatment are transferred 
to Eastern Maine Medical Center. Depending on the circumstances, the mother may or may not 
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be transferred with the newborn; typically, the mother has been discharged from the hospital and 
must travel to visit the hospitalized newborn. 
Access to treatment for substance use disorders is limited, with one outpatient practice in 
Washington County and two in Penobscot County, none of which are designed specifically to 
address the unique needs of pregnant and parenting women. In contrast, comprehensive 
integrated outpatient services for pregnant and parenting women with substance use disorders, 
including medical, behavioral, and mental health services, are available in the more densely 
populated southern areas of the state.  
Women living in Washington County receive a flexible, individualized, strength-based, 
integrated, collaborative, wrap-around model of care delivery linking them with various services, 
while those in Penobscot County must access those services with limited case management and 
without the characteristics of the Washington County model. It has been identified that women 
living in remote rural geographic areas with fewer resources who may experience greater 
obstacles to accessing services are underrepresented in current studies. The barriers to accessing 
adequate resources for substance use disorder recovery, pregnancy, and parenting support, 
addressed earlier in this proposal, are clearly present in this setting. Such a setting provides the 
opportunity to further explore the factors contributing to unmet needs and potential determinants 
of the problem. 
Population 
 The general target population identified for this study will broadly include women living 
in Washington and Penobscot Counties identified with a substance use disorder inclusive of 
opioid use who deliver their babies at Eastern Maine Medical Center. Clinically important 
neonatal withdrawal most commonly results from intrauterine opioid exposure (Hudak & Tan, 
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2012), and 56% of substance-exposed infants born at Eastern Maine Medical Center in 2011 
were identified as being opiate-exposed. This is a heterogeneous population with respect to 
substances used and stage of recovery in addition to the complex array of biopsychosocial, 
environmental, and economic variables influencing substance use disorder and recovery (M. 
Brown, M. Moran., & M. Withers, personal communication, August 5, 2014).   
Sample and Sampling Procedures 
 The sample will be purposefully selected using maximum variation sampling strategies to 
observe a range of informants and activities in a variety of contexts according to demographic, 
phenomenal, and theoretical categories (Sandelowski, 1995b). Participants may be of any 
race/ethnicity, social class, relationship status, pregnancy status, child custody status, and stage 
of recovery. Inclusion criteria for all participants are: (a) have a newborn hospitalized at Eastern 
Maine Medical Center, either from birth or through transfer from a smaller facility; (b) have an 
identified substance use disorder that includes current use of an opioid (legally prescribed 
medication assisted treatment, misuse of prescription opioid medications, or illicit opioids); and 
(c) live within Washington or Penobscot County. Participants must be English-speaking and able 
to give informed consent.  
Sample selection. Sample selection will be dictated by availability and willingness of 
participants meeting inclusion criteria as well as establishment of trust with potential informants. 
Sampling decisions are dictated by the emergence of data with the intention of including units of 
observation (settings, individuals, and activities) representative of pre-selected variables as well 
as typical or unusual cases (Sandelowski, 2000).  
Sample size. Sample size will be determined as the study evolves; as noted by 
Sandelowski (1995b), sample size is a matter of judgment and depends on breadth and depth of 
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the data that emerge. Distinction is made between informational redundancy (no new 
information is available from newly sampled units) and theoretical saturation (data has been 
gathered and analyzed from all theoretical categories) (Coyne, 1997; Sandelowski, 1995b). Data 
collected and analyzed concurrently will inform sample configuration and size decisions based 
on the richness and variation found in the data. In the proposed study, participants will be 
selected that vary as much as possible according to various demographic characteristics based on 
literature and personal communication with expert practitioners (Gilligan et al., 2009; Gray, 
Edwards, Schultz, & Miranda, 2014; M. Brown, M. Moran., & M. Withers, personal 
communication, August 5, 2014): (a) race/ethnicity, (b) social class, (c) relationship status, (d) 
pregnancy status, (e) child custody status, (f) stage of recovery, and (g) county of origin (see 
Appendix A). This information will be gleaned from the health care record and informant self-
disclosure and recorded by the researcher on a demographic data form. The researcher will aim 
for a sample size of 20 to 30 informants to achieve the goal of maximum variation. 
Data Collection Procedures 
 Institutional review board (IRB) approval will be sought from Duquesne University and 
Eastern Maine Medical Center; data collection will commence upon these approvals as well as 
permission received from physician and nursing leadership at Eastern Maine Medical Center. 
Data will be collected primarily through participant observation, oral accounts and formal 
interviews, and artifact review. It is anticipated that data will be collected over several months. A 
reflective journal will be maintained by the researcher throughout the data collection, 
preparation, organization, and analysis process to record memos regarding methodological issues 
and decisions and personal impressions as well as to facilitate thinking and stimulate insight 
(Maxwell, 2013).  
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Participant recruitment. A letter explaining the study and inviting eligible women to 
participate will be drafted by the researcher for distribution by providers of care for the women. 
Such providers will include but not be limited to prenatal care practices and substance use 
services. Included with the letter will be a postcard with a self-addressed, stamped envelope 
which a woman can return to the provider if interested in being contacted post-delivery by the 
researcher during the mother’s and/or baby’s hospitalization at Eastern Maine Medical Center. 
This information will be shared only with the primary team responsible for care of the women 
and infants at Eastern Maine Medical Center; the researcher will have no prior knowledge of the 
women’s identities. The letter will explain that the researcher will be notified by the perinatal 
health care team when she has delivered her baby; only then will the participant be contacted by 
the researcher for informed consent, Health Insurance Portability and Accountability Act 
(HIPAA) Privacy release, and data collection. 
Due to the vulnerability of this population, it is important to maintain the privacy of 
potential informants until they have agreed to be contacted. Contacts have been made with 
several prominent practice directors (Marjorie Withers, LCPC, Director, Community Caring 
Collaborative; Mark Brown, MD, Chief of Pediatrics & Neonatology, Eastern Maine Medical 
Center), and through meetings, e-mail, and telephone communication the researcher has 
delineated the research purpose and plan to conduct the study with women in their service areas. 
They have given support for the study and have arranged contacts with professionals working in 
the field who will be instrumental as gatekeepers in identifying potential informants and 
facilitating recruitment as previously outlined.  
Potential informants will be approached inconspicuously at the hospital as facilitated by 
the gatekeepers and permission will be requested to discuss the study. Care will be taken to 
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assure privacy during this discussion. Discussions and subsequent interviews will take place in 
the woman’s private hospital room or in a private office designated by the gatekeepers, 
depending on the woman’s preference and comfort. The presence of family members and friends 
will influence the discussion timing and location. The study aim will be explained to the 
informant as follows: “I am interested in learning more about how women who have infants and 
are also dealing with substance use feel about the care they received during their pregnancy and 
since the baby was born. I am also hoping to learn more about how this care has affected mothers 
bonding with their babies. I want to learn all this so nurses can take better care of women and 
their babies”. The details of data collection and management will be discussed and questions will 
be answered, followed by written consent and HIPAA release. Women consenting to participate 
in the study will be offered a gift card to a local merchant.  
Participant observation. Participant observations occur in social situations identified by 
places, people, and activities (Spradley, 1980). As noted by Hammersley and Atkinson (2007), 
selection of settings and cases in ethnographic research often occurs on the basis of 
foreshadowed problems and pre-fieldwork, and the researcher may not be able to stipulate these 
details in advance.  Observations will take place in the perinatal units at Eastern Maine Medical 
Center facilitated by the providers with whom the researcher communicated during pre-
fieldwork, specifically the neonatologist and social worker who care for the women and their 
babies at Eastern Maine Medical Center.  
Participation may occur on a spectrum from non-involvement to complete involvement as 
an ordinary participant (Spradley, 1980). It is anticipated that participation in the settings 
described would be passive to moderately engaged, depending on the comfort and trust of the 
participants and the researcher’s familiarity with the activities. The researcher understands that 
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practitioners and staff may have concerns about inclusion in these observations. The cultivation 
of good field relations includes impression management and addressing concerns of those 
working in the field (Hammersley & Atkinson, 2007). A fact sheet about the study will be 
drafted by the researcher for distribution to staff and the researcher will be available to answer 
questions and concerns (Appendix B1). Family and friends may express similar concerns; a fact 
sheet will available for them, as well (Appendix B2). 
As noted by several authors, pregnant and parenting women with substance use disorders 
have been reported to experience stigma, fear, shame, and guilt, as well as high rates of co-
occurring mental health problems, trauma, and post-traumatic stress disorder (Brandon, 2014; 
Haug, Duffy, & McCaul, 2014). Therefore, it is important to begin any field observation as 
unobtrusively yet transparently as possible to cultivate trust. Informal questions may be asked of 
practitioners and staff prior to approaching potential participants to understand and clarify 
observed behaviors and practices.  
Observations also range from broadly descriptive to more narrowly focused and selective. 
Observations may occur over the span of several days while the woman and/or her baby are 
hospitalized and will be centered on: (a) participant behavior and demeanor during interviews 
and in the hospital environment; (b) interactions between participants and others in the 
environment; (c) behavior and demeanor of others in the environment during interactions with 
the participants; and (d) the environment and context of care. The purpose of such observations 
will be to enhance the researcher’s understanding of informant reports. An observation guide will 
be used to focus attention on only the most salient observations (see Appendix C). Observations 
will be recorded through handwritten jottings and detailed fieldnotes while in the practice 
settings if this can be accomplished discreetly. Descriptions may also be spoken into a digital 
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recorder when no participants are present and then transcribed into written fieldnotes for 
analysis. Jottings and fieldnotes will be reviewed immediately following each observation and 
amended as needed to ensure completeness and accuracy and to facilitate validation of findings 
(Maxwell, 2013).    
 Oral accounts and formal interviews. Spradley (1979) defines speech events as casual 
conversations and formal interviews which may serve to validate observations. In this study, the 
purpose of oral accounts and formal interviews will be to glean the women’s accounts of their 
experiences and perceptions of the care they received during their pregnancy and throughout 
their hospitalization as well as what factors of that care may affect their ability to bond with their 
infant.  
 Three main types of interview questions (descriptive, structural, and contrast) will be 
used and will be structured as suggested by Spradley (1979). Descriptive grand tour questions 
are loosely structured and allow the informants freedom of expression; an example would be: 
“Can you tell me about the care you received during your pregnancy?” Grand tour questions may 
then lead to mini-tour, example, experience, and native-language questions. Examples include: 
“Can you describe the process of making that appointment?”, “Can you give me an example of a 
time you felt accepted/judged?”, “What are some of the experiences you’ve had trying to make 
appointments?”, and “How would you refer to someone who made you feel that way?” Structural 
and contrast questions are more directive and may be used for additional clarification; examples 
of such questions may include: “What is the process for scheduling appointments?” and “How 
was that experience different from the one you described previously?” An interview guide will 
be used to frame the more general research questions; more specific questions will evolve as the 
oral accounts and interviews progress (Appendix D). 
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 Oral accounts and formal interviews will be recorded through handwritten notes and 
digital recorder, depending on the comfort of the informant. Interviews will likely vary greatly in 
length, depending on informant comfort and any time constraints. Digital recordings will be 
transcribed verbatim by an experienced professional transcriptionist as soon as possible after 
each interview. Additionally, all recordings, the transcripts, and the fieldnotes will be reviewed 
by the principal investigator as soon as is feasible to ensure completeness and accuracy. Process 
notes will be written following interviews to record observations such as body language, facial 
expressions, and general impressions. 
 Artifact review. Data in the form of documents and material artifacts may provide 
additional information about study settings and serve to either corroborate or challenge 
information from observations or informants (Hammersley & Atkinson, 2007). These material 
goods may take the form of agency records, informational literature, educational brochures, and 
aesthetic features of settings. After consent, pertinent demographic data and relevant health and 
social information, such as pregnancy status, self-reported/laboratory confirmed substance use, 
and child custody, will be accessed from agency records (Appendix E). Samples of publicly 
available information relevant to the study, such as pamphlets and brochures, may be gathered. 
Details of aesthetic characteristics of the setting, such as posters, signage, and artwork, may be 
recorded through handwritten notes or digital audio or video recording depending on the 
propriety to the situation. 
Plans for Data Analysis 
 Analysis of ethnographic data is an evolving and iterative process, occurring 
concomitantly with data collection, preparation, and organization to make meaning and search 
for patterns (Hammersley & Atkinson, 2007; Spradley, 1979). Fieldnotes and transcriptions will 
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be reviewed and proofed against recorded data for accuracy and to serve as preliminary analysis 
to guide subsequent data collection (Sandelowski, 1995a). All data will be entered into the 
current version of NVivo computer-assisted qualitative data analysis software (CAQDAS) for 
organization and assistance with analysis.  
Once entered, data will be coded, or categorized, according to the process described by 
Maxwell (2013). Coding labels are applied to units or segments of data that appear significant or 
relevant in some way and are then explored and compared both within and between cases and 
categories. Organizational categorization is the broadest level of ordering the data and may be 
established prior to observations and interviews. The participant characteristic matrix (Appendix 
A) will facilitate organization of cases for later comparison. As data collection progresses, 
constant comparison will be used to create substantive (descriptive) and theoretical (abstract) 
categories; annotations and analytic memos will be written to assist with this process and 
subsequent comparison within and between cases. Substantive categories reflect the “emic” 
view, informant perspectives in their own words taken from recorded data. Theoretical categories 
emerge from the researcher’s “etic” interpretation of the data. Data matrices will be developed 
from the coding schema to organize and display categories and establish emerging themes. 
 Validity is related to the accuracy of interpretation of the data and is an important step in 
analysis. Creswell (2009) proposed the terms trustworthiness, authenticity, and credibility to 
describe validity and suggested a number of validation strategies which are reiterated by 
Maxwell (2013). Triangulation involves collection of information from a variety of information 
sources to build justification of themes, which are enumerated in the procedures for data 
collection. Documentation and analysis of observations, interviews, and artifacts will contain 
thick, rich description of data. Feedback, also known as respondent validation or member 
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checking, will be solicited from informants to determine accuracy of conclusions. Reflective 
journaling will serve to both document analytic decisions and identify possible personal biases. 
Although this researcher has some experience with this population, a relatively unfamiliar study 
setting has been chosen to promote a more objective stance. A search for negative or discrepant 
information adds to the credibility of the findings and will be addressed through discussion of 
impressions with dissertation committee members. Additionally, notes, transcripts, and access to 
CAQDAS files will be shared with dissertation committee members to facilitate review and 
recommendations. 
Study Limitations 
 An ethnographic study of this population may pose certain limitations related to the 
reliability and authenticity of information obtained from the informants. The participant pool 
may be skewed by gatekeeper bias toward informants deemed more reliable or favored in some 
way. Reactivity, or observer effect, may influence how forthright the women might be. 
Additionally, the sample size may be restricted due to fluctuations in women meeting inclusion 
criteria, their availability and willingness to participate, and attrition. Such limitations will be 
addressed by the researcher remaining flexible and opportunistic in observations. Casual 
conversations and formal interviews will be augmented with observational and artifact data. 
Interviews questions will be varied and structured to encourage honesty while remaining 
sensitive to the informants’ vulnerability.  
Potential Procedural Problems and Strategies to Address 
 A number of constraints may be anticipated when conducting fieldwork with a vulnerable 
population, particularly within the limitations posed by doctoral dissertation work. Given the 
complex challenges of this population, recruitment and retention may be difficult, which is 
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closely aligned with development of rapport and establishing trust with both service providers 
and prospective informants. Prospective informants will be identified on the advice of those 
gatekeepers.  
Informants who have consented to participate in the study may experience barriers to 
completing the study. The mothers who did not deliver their babies at Eastern Maine Medical 
Center or who have already been discharged without their babies may experience logistical 
challenges, such as undependable transportation and child care for other children. Women may 
also be dealing with challenges such as postpartum discomfort and fatigue, distressing family 
and social circumstances, and child protective services involvement. The researcher must be 
compassionate and flexible in the scheduling of appointments for formal interviews.   
The researcher must be prepared to address disclosure of sensitive information or 
potentially illegal activities, particularly if such disclosure suggests child maltreatment. The 
informed consent process will include a discussion of mandated reporting. Additionally, the 
researcher will collaborate with the hospital social worker to anticipate potential disclosure. In 
cases that may not be straightforward, the researcher will consult with her dissertation committee 
chair. 
Timeline 
 It is anticipated that once this proposal has been successfully defended and the study is 
approved, IRB approval will be sought by November 2014 and the study site secured by 
December 2014. Recruitment activities will commence and data collection will begin. Data 
collection will continue until data saturation or informational redundancy is recognized. Data 
analysis will begin immediately and continue throughout the project. Dissertation defense will 
occur once the final analysis has been completed. Final results of the study will be disseminated 
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through manuscript submission in a peer-reviewed journal upon successful defense. Due to the 
evolving nature of qualitative studies, the exact timeframe for dissertation defense and 
dissemination of results cannot be predetermined. 
Protection of Research Participants 
 IRB approval will be obtained from Duquesne University and Eastern Maine Medical 
Center, Bangor, Maine. Directors of agencies and practices where potential informants will be 
recruited will be approached to obtain permission for letters to be drafted to be given to 
prospective informants. The issue of informed consent in qualitative research, particularly 
ethnographic studies where interaction with informants may vary over time, has been debated by 
a number of researchers (Munhall, 2012). The emergent nature of ethnographic research and the 
spectrum of researcher participation from passive observation to active involvement raise the 
questions of who must give written informed consent and when that consent is obtained. Munhall 
(2012) proposed the concept of process consent whereby permission is renegotiated with each 
interaction. Written informed consent will be obtained from informants upon initial contact and 
reaffirmed verbally with any subsequent interaction. HIPAA release will also be obtained prior 
to review of any agency records. Information sheets explaining the study will be distributed to all 
staff involved in the care of the prospective informants. Verbal consent will be obtained from 
persons not directly involved in the study but who may become part of the data collection 
through their interaction with prospective informants (such as friends and family members).  
Potential risks to informants and participants include breach of anonymity and 
confidentiality. To minimize these risks, permission will be requested prior to any dialogue, and 
conversations and interviews will be conducted privately. All protected health information will 
be de-identified and each case will be assigned a number which will be used on all digital files, 
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transcripts, fieldnotes, and journal notes. All forms of data will be stored in a locked file cabinet 
accessible only to the principal investigator. Electronic files will be preserved on a secure 
password protected computer, and electronic transfer of data to the researcher’s dissertation chair 
will be accomplished through encrypted files. Digitally recorded data will be retained until 
analysis is completed; following completion of dissertation research, data will remain secure at 
Duquesne University School of Nursing for five years. 
Registered nurses in the state of Maine are mandated to report to the Department of 
Health and Human Services any suspicion of child abuse, neglect, or exploitation. This places a 
limit on the assurance of confidentiality, which will be outlined in the informed consent process. 
The researcher acknowledges that such a justifiable breach of confidentiality may affect 
recruitment and retention of participants; however, it is imperative that child welfare take 
precedence over potential harm to participants (Fisher, 2009).  
Informants may also be at risk for emotional distress by discussing their experiences. 
Informants will be reminded that any sharing of information is completely voluntary, that they 
can choose to withhold information or withdraw from the study at any time, that admission of 
use of illegal substances will not be revealed to anyone, and that any information shared will not 
influence their care. Should informants express any distress, referral will be made to the 
appropriate service provider. 
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Appendix A: Potential participant characteristics 
 
 Race/ethnicity Social 
class 
Relationship Pregnancy Child 
Custody 
Recovery Location 
Race/ethnicity        
Social class        
Relationship         
Pregnancy         
Child custody         
Recovery        
Location        
 
A. Race/ethnicity 
1. White 
2. Native American 
3. Other 
B. Social class  
1. Income 
2. Education 
3. Employment 
C. Relationship status (includes all combinations of sexual preferences and partnership 
arrangements) 
1. Single, never married 
2. Single but previously married 
3. Married 
4. Committed but unmarried 
5. Other 
D. Pregnancy status (gravidity/parity) 
1. Primiparous 
2. Multiparous 
E. Child custody status (includes family and non-family custody arrangements) 
1. Fully retained custody 
2. Fully relinquished custody 
3. Shared custody 
F. Stage of recovery 
1. Active recovery (adherent to MAT, no illicit substance use) 
2. Relapse (on MAT with continued illicit substance use) 
3. Pre-recovery (illicit substance use, no MAT) 
G. County of origin 
1. Washington 
2. Penobscot 
3. Other 
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Appendix B1 
Fact Sheet 
 (Postpartum and neonatal care - Hospital Personnel) 
 
Duquesne University School of Nursing 
Information about a Research Study 
________________________________________________________________________ 
IRB Study #   Consent Form Version Date:  
 
Title of Study: Experiences and Perceptions of Postpartum Women with Substance Use 
Disorders Inclusive of Opioids Regarding Their Care 
 
Principal Investigator: Debra Kramlich, MSN, RN, CCRN 
Duquesne University Department: School of Nursing 
Study Contact Telephone Number: xxx-xxx-xxxx  
Study Contact Email: kramlichd@duq.edu 
 
Faculty Advisor: Rebecca Kronk, PhD, MSN, CRNP 
Duquesne University Telephone Number:  xxx-xxx-xxxx  
Email: kronkr@duq.edu  
________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  You may 
refuse to join, or you may withdraw your consent to be in the study, for any reason, without 
penalty.  
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. 
 
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.  You will be given a 
copy of this consent form.  You should ask the researchers named above, or staff members who 
may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study?  
The purpose of this research study is to better understand the experiences and perceptions of 
postpartum women with substance use disorders inclusive of opioids regarding their care. 
 
How many people will take part in this study? 
There will be approximately 20 to 30 women asked to participate in this study. Hospital 
personnel may also be observed. These personnel may be asked questions to help the researcher 
understand what is going on. 
   
How long will your part in this study last?  
You may be observed while engaging in normal activities and routines in the setting. You may 
be asked some informal questions to clarify information and help the researcher understand what 
is going on. Time spent to answer some questions should be approximately 10-20 minutes. 
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What will happen if you take part in the study 
I will observe the women in the neonatal care area as they interact with their babies, family 
members, other mothers, and hospital staff. The focus of the observations will be on the women. 
I will not interfere in the women’s care in any way. I will take notes about the physical setting 
and what is happening during care. 
 
I may ask you questions about your work with women who have experienced substance use 
disorders and their babies. I may also ask you to clarify activities that were seen or heard during 
my observations. This will be done only after the observations are completed. I will take notes 
about what you say. You do not have to answer any questions that you do not wish to answer, for 
any reason. 
 
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge. Your participation is 
important to help healthcare providers learn about the experiences and perceptions of postpartum 
women with substance use disorders regarding the care they receive. You will not likely benefit 
personally from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study? 
I do not anticipate you will experience any discomfort or risk from being observed or asked some 
informal questions.   
 
How will your privacy be protected?   
I will not use your name in any handwritten notes or audio recorded notes. Your name will not 
be used when presenting this research to others. You will only be identified in the researcher’s 
notes by your profession (e.g., nurse, physician, aide, social worker).   
 
Will you receive anything for being in this study? 
You will not receive anything for being in the study. 
 
Will it cost you anything to be in this study? 
There are no costs to you for being in the study. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions, or concerns, you should contact me or my academic advisor using the 
contact information listed at the beginning of this form.  
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject you may 
contact, anonymously if you wish, the Institutional Review Board at __________ or by email to 
_____________. 
 
Thank you for helping me with this study. 
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Appendix B2 
Fact Sheet 
 (Postpartum and neonatal care - Family) 
 
Duquesne University School of Nursing 
Information about a Research Study  
________________________________________________________________________ 
IRB Study #   Consent Form Version Date:  
 
Title of Study: Experiences and Perceptions of Postpartum Women with Substance Use 
Disorders Inclusive of Opioids Regarding Their Care 
 
 
Principal Investigator: Debra Kramlich, MSN, RN, CCRN 
Duquesne University Department: School of Nursing 
Study Contact Telephone Number: xxx-xxx-xxxx  
Study Contact Email: kramlichd@duq.edu 
 
Faculty Advisor: Rebecca Kronk, PhD, MSN, CRNP 
Duquesne University Telephone Number:  xxx-xxx-xxxx  
Email: kronkr@duq.edu  
________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  You may 
refuse to join, or you may withdraw your consent to be in the study, for any reason, without 
penalty.  
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. 
 
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.  You will be given a 
copy of this consent form.  You should ask the researchers named above, or staff members who 
may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study?  
The purpose of this research study is to better understand the experiences and perceptions of 
postpartum women with substance use disorders inclusive of opioids regarding their care. 
 
How many people will take part in this study? 
There will be approximately 20 to 30 women asked to participate in this study. Hospital 
personnel and family members may also be observed in the hospital setting.  
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How long will your part in this study last?  
You may be observed while in the hospital setting (most likely your family member’s hospital 
room or in the common family area). You will only be observed when with your family member.  
 
What will happen if you take part in the study 
I will observe the women in the neonatal care area as they interact with their babies, family 
members, other mothers, and hospital staff. The focus of the observations will be on the women. 
I will not interfere in the women’s care in any way. I will take notes about the physical setting 
and what is happening during care. 
 
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge. Your participation is 
important to help healthcare providers learn about the experiences and perceptions of postpartum 
women with substance use disorders regarding the care they receive. You will not likely benefit 
personally from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study? 
I do not anticipate you will experience any discomfort or risk from being observed.  
 
How will your privacy be protected?   
I will not use your name in any handwritten notes or audio recorded notes. Your name will not 
be used when presenting this research to others. You will only be identified in the researcher’s 
notes by your relationship to the patient (e.g., husband, sister, friend).  
 
Will you receive anything for being in this study? 
You will not receive anything for being in the study. 
 
Will it cost you anything to be in this study? 
There are no costs to you for being in the study. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions, or concerns, you should contact me or my academic advisor using the 
contact information listed at the beginning of this form.  
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject you may 
contact, anonymously if you wish, the Institutional Review Board at __________ or by email to 
_____________. 
 
Thank you for helping me with this study. 
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Appendix C: Observation guide (adapted from Spradley, 1980) 
 
 Focus areas for observations: 
1. Participant behavior/demeanor during interviews 
2. Participant behavior/demeanor in the hospital environment 
3. Participant interactions with staff 
4. Participant interactions with newborn 
5. Participant interactions with friends/family members 
6. Participant interactions with other patients (if appropriate – as an example, if 
several consenting participants happen to be interacting in common areas on the 
unit, this interaction would be observed) 
7. Staff interactions specifically involving consenting participants (as an example, 
change of shift report, interdisciplinary report) 
8. Behavior/demeanor of others in the environment during interactions with 
participants 
9. Contextual/environmental factors impacting behavior and interaction 
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Appendix D: Interview guide (adapted from Spradley, 1979) 
 
Interviews will start with broad, open-ended grand tour questions; subsequent questions will be 
based on the answers to the grand tour questions. 
 Topic areas to be covered: 
1. Care received during pregnancy 
a. Experiences of making appointments 
b. Experiences of getting to appointments 
c. Interactions with care providers 
2. Hospital experiences 
a. Experiences of being in the hospital 
b. Experiences of getting to the hospital (if  mother discharged and baby still 
there) 
c. Interactions with care providers  
d. Preparation for discharge 
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Appendix E 
 
Medical Record Data Extraction Guide 
 
Demographics: 
Age ________ 
Race/ethnicity _________________ 
County of origin _______________________ 
Education ____________________ 
Employment status ________________________ 
Income level (may be deduced from public assistance status) ________________ 
Marital status ____________________ 
Others in Household 
None ______ 
Partner _______ 
Children _______ 
Others ________ 
Child custody status ______________________ 
Medical Information:  
Pregnancy status ___________________ 
Substance(s) used __________ 
Stage of substance use recovery ________________ 
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Challenges and Facilitators of Recruitment: Lessons Learned from Conducting a 
Focused Ethnography in a Vulnerable Rural Population 
Debra Kramlich, Rebecca Kronk, and Karen Jakub 
Duquesne University 
Abstract 
The purpose of this article is to describe the challenges and facilitators of 
recruitment encountered in an ethnographic dissertation study of rural women with 
substance use disorders during the perinatal period. While the study is being 
conducted in the hospital setting post-delivery, potential participants who meet 
inclusion criteria are identified by practitioners through a number of perinatal 
practices within a wide geographic area as well as by inpatient social workers. 
Recruitment in this vulnerable and often socially disadvantaged population has 
been found to be challenging with regard to ethical approval, participant eligibility 
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and availability, practice changes, and discrepancies in the recruitment process. The 
authors discuss these challenges and describe the process of practitioner 
engagement to facilitate participant recruitment and lessons learned in the process. 
Keywords: Ethnography, Vulnerable Population, Socially Disadvantaged, 
Recruitment Challenges 
 
Background 
The first author (herein referred to in the first person) lives in a rural area in the 
northeastern United States identified as having one of the highest rates of prescription opiate 
drug misuse and neonatal abstinence syndrome (NAS) in the country (Hayes & Brown, 2012; Ko 
et al., 2016). As a registered nurse caring for newborns with NAS, I was concerned with this 
trend and sought to better understand the determinants of the issue. This interest led to a search 
of the evidence and subsequent focus of the current dissertation study. The second and third 
authors serve as my advisor/dissertation committee chair and methods expert, respectively, 
providing continuous consultation throughout the process. 
Women with substance use disorders continue to face numerous impediments to 
accessing available resources for recovery and parenting support (Fraser, Barnes, Biggs, & Kain, 
2007). Substance use disorder in women is associated with increased prevalence of mental 
illness, histories of physical and sexual abuse, and medical and social problems (Milligan et al., 
2010). Pregnant and parenting women with substance use disorders have been reported to 
experience stigma, fear, shame, and guilt, as well as high rates of co-occurring mental health 
problems, trauma, and post-traumatic stress disorder (Brandon, 2014; Haug, Duffy, & McCaul, 
2014). Studies have shown that rural healthcare disparities, specifically those related to poverty, 
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further complicate access to treatment, and societal stigma and lack of resources further 
contribute to the negative outcomes for both mother and child (Lander et al., 2013). This is 
particularly concerning in light of findings that protective factors, such as caretaker involvement 
and family resources, may moderate the negative effects of substance use on the developing 
child (Bada et al., 2012).  
Of newborns prenatally exposed to addictive substances, 50% to 90% will experience 
some degree of neonatal abstinence syndrome (NAS), a term applied to a constellation of 
symptoms characterized by dysregulation and hyperirritability of the central and autonomic 
nervous, respiratory, and gastrointestinal systems (Sublett, 2013). Symptoms are treated with a 
combination of pharmacologic and non-pharmacologic therapies typically requiring specialized 
neonatal care with an overall mean length of hospital stay of 16 days, increasing to 23 days for 
newborns requiring pharmacologic treatment (Patrick, Davis, Lehman, & Cooper, 2015). Despite 
increasing attention on this problem and evidence-based recommendations (Dow et al., 2012; 
Goettler & Tschudin, 2014; Hudak & Tan, 2012; Jansson, Velez, & Harrow, 2009; Lucas & 
Knobel, 2012; Queensland & Neonatal Clinical Guidelines, 2010; Winklbaur et al., 2008), 
management remains inconsistent, hospital length of stay has not declined, and expenditures 
continue to rise (Patrick et al., 2015).  
Perinatal substance use directly impacts two constituencies, the woman and her offspring, 
and therefore the problem has been examined from a variety of perspectives. Numerous 
quantitative studies have been conducted to identify factors regarding maternal drug use which 
may be predictive of neonatal outcomes, such as the type and amount of medication-assisted 
treatment for opioid use. Several retrospective studies associated higher doses of maternal 
methadone dose with higher incidence of neonatal abstinence syndrome as well as duration of 
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neonatal abstinence syndrome treatment (Dryden, Young, Hepburn, & Mactier, 2009; Lim, 
Prasad, Samuels, Gardner, & Cordero, 2009). These findings contradicted those of other studies, 
which reported no such correlation (Pizarro et al., 2011; Seligman et al., 2008). One prospective 
cohort study also concluded that the incidence and duration of neonatal abstinence syndrome was 
not affected by methadone dose (Cleary et al., 2012). McCarthy, Leamon, Stenson, and Biles 
(2008) noted that infants of women who began methadone treatment prior to conception had 
better outcomes compared with those whose mothers began treatment mid-pregnancy.  
Similar conflicting results have been noted in studies comparing maternal methadone and 
buprenorphine medication-assisted treatment. Several studies suggested improved neonatal 
outcomes, such as lower incidence and severity of neonatal abstinence syndrome, in infants 
exposed to buprenorphine as compared with methadone exposure (Binder & Vavrinkova, 2008; 
Coyle et al., 2012; Gaalema et al., 2012; Kakko, Heilig, & Sarman, 2008; Salisbury et al., 2012). 
Other studies found no such differences (Jones et al., 2010; Welle-Strand et al., 2013). Patel and 
colleagues (2013) noted no difference in neonatal abstinence syndrome expression when 
comparing infants exposed to buprenorphine to those exposed to illicit opiates. The concomitant 
use of illicit substance, as well as alcohol and tobacco, with medication-assisted treatment seems 
to confound the results of these studies (Blandthorn, Forster, & Love, 2011; Kaltenbach et al., 
2012).  
Many of the aforementioned studies have been retrospective reviews of clinical data or 
secondary analyses of data from larger studies. Findings of several prospective studies regarding 
severity of neonatal abstinence syndrome relative to type and dose of maternal substance or 
medication-assisted treatment have been equally conflicting. Winklbaur-Hausknost and 
colleagues (2013) found that maternal treatment resulting in reduced illicit drug use throughout 
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pregnancy had no influence on neonatal outcomes in two separate studies. In a systematic review 
and meta-analysis, Cleary and colleagues (2010) found no clear link between neonatal abstinence 
syndrome severity and methadone dose. Similarly, Thajam, Atkinson, Sibley, and Lavender 
(2010) found no correlation between amount and type of fetal opioid exposure and neonatal 
abstinence syndrome expression in eight of the 10 studies they reviewed. In a systematic review 
of the literature, Milligan and colleagues (2010) noted that quantitative and interventional studies 
have yet to produce sustained, efficacious improvement in outcomes for these mothers and 
children. It may be concluded that a singular focus on drug type and dose fails to account for the 
complex array of factors contributing to neonatal outcomes. 
Literature regarding care of the newborn with neonatal abstinence syndrome has been 
equally inconclusive (Dryden, Young, Hepburn, & Mactier, 2009; Sublett, 2013; Velez, Jansson, 
Schroeder, & Williams, 2009). It appears that factors other than maternal medication-assisted 
treatment, such as maternal-infant bonding, have greater influence on neonatal outcomes:  
 Care of neonatal abstinence syndrome infants on the postpartum unit with their 
mothers, rather than in the NICU, resulted in shorter duration of treatment and 
hospital stay (Saiki, Lee, Hannam, & Greenough, 2010).  
 Infants discharged home on a methadone weaning protocol with support from a 
multidisciplinary team, as opposed to a traditional inpatient methadone wean, 
resulted in shorter hospital stays and reduced cost (Backes et al., 2012; Smirk, 
Bowman, Doyle, & Kamlin, 2014) . 
 Substantial breast milk intake significantly reduced severity of neonatal 
abstinence syndrome symptoms, delayed the onset of symptoms, and decreased 
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the need for pharmacologic treatment (Abdel-Latif et al., 2006; Dryden et al., 
2009).  
Early and adequate prenatal care has been shown to mitigate the negative effects of 
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning, 
2012). Studies of early identification, engagement, and treatment retention of pregnant women 
using integrated substance abuse and perinatal services are showing potential benefits in the 
promotion of maternal-infant bonding (Burns, Mattick, Lim, & Wallace, 2007; Mayet, 
Groshkova, Morgan, MacCormack, & Strang, 2008; Meyer et al., 2012; Racine, Motz, Leslie, & 
Pepler, 2009; Suchman, Pajulo, DeCoste, & Mayes, 2006; Taylor et al., 2012). In a recently 
published systematic review, Jumah (2016) identified location as a major factor in accessibility 
to treatment for rural, opioid-dependent pregnant women, yet she also noted that gender issues 
and stigma remain largely unaddressed in the literature. Studies of harm-reduction approaches in 
Britain, the Netherlands, and Canada have shown positive outcomes in terms of lower rates of 
child protective involvement and withdrawal symptoms in infants (Boyd & Marcellus, 2007). 
Pilot studies in the U.S. have shown similar results (Wright et al., 2012). The programs described 
in the literature have used a variety of interventions, including integrated prenatal and substance 
abuse services and motivational incentives, so it is unclear which aspects of a harm-reduction 
approach contribute to outcomes. A focused review of the literature, highlighting studies of 
perinatal substance use disorders that included health care provider-mother-infant relational 
perspectives within various care delivery models, concluded that published studies have yet to 
identify the relative contribution of multiple risk factors to adverse outcomes as well as program 
components most likely to improve outcomes (Kramlich & Kronk, 2015).  
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It would seem from this review of the literature that the voice of pregnant and parenting 
women with substance use disorders has been minimally included in prior studies as evidenced 
by the relatively limited number of qualitative studies. Woodley and Lockard (2016) noted that 
qualitative research methods may provide more opportunities to engage with marginalized 
groups through personal connections as compared to quantitative methods, therefore informing 
my choice of study design.  My dissertation study aims to address the gaps in the literature by 
exploring the women’s experiences and perceptions of care, leading me to ask several questions: 
a) What are the experiences and perceptions of women with substance use disorder regarding the 
care they received during their pregnancy and through their infants’ hospitalization? and b) How 
have their experiences supported or inhibited their ability to bond with their baby? For research 
purposes, pregnant women, human fetuses, and neonates are identified as vulnerable populations 
and are afforded additional protection (Protection of Human Research Subjects, 2001). 
Additionally, Flaskerud and Winslow (1998) suggest that persons who are poor, subjected to 
discrimination, intolerance, subordination, stigma, politically marginalized, disenfranchised, and 
denied human rights may be considered vulnerable. Studies have shown that women with 
substance use disorder, particularly those who are poor, indigenous, and members of racial 
minorities, “are the most vulnerable to arrest, child apprehension, and poor health outcomes” 
(Boyd & Marcellus, 2007, p. 14). Access to and engagement of participants from vulnerable, 
socially disadvantaged populations have been found to be challenging due to mistrust of 
research/researchers and fear of authority, public exposure, and potential harm, stigma, 
mistreatment, or exploitation (Bonevski et al., 2014). For the reasons noted above, pregnant and 
parenting women with substance use disorder may be reluctant to participate in research studies 
due to the perceived and real risk of prosecution and incarceration, particularly in light of the 
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criminalization of drug use during pregnancy in several states (Miranda, Dixon, & Reyes, 2015). 
Gatekeepers may serve as both barriers to and facilitators of participant recruitment; the 
relationship between vulnerable individuals and the health professionals caring for them may 
potentially inhibit the recruitment process (Bonevski et al., 2014; Namageyo-Funa et al., 2014).  
Study Purpose and Design 
Women living in remote rural geographic areas with fewer resources who may 
experience greater obstacles to accessing services have been underrepresented in prior studies. 
An exploration of the experiences of women with substance use disorder regarding the care they 
received for pregnancy, parenting, recovery, and psychosocial and economic issues is being 
undertaken to identify unmet needs. It is hoped that results of the study may contribute to a better 
understanding of the determinants of the problems associated with perinatal substance use to 
inform development of efficacious models of care. These findings may be of particular interest to 
the health care and psychosocial support services professionals who care for these women, as 
well as policymakers tasked with addressing issues related to substance use disorders.   
Ethnographic studies are designed to understand a culture by learning from the people 
within that culture through contextualized examination of their speech, behavior, and artifacts 
(Spradley, 1979). Focused ethnography, defined by Munhall (2012) as “the study of small 
elements of one society, group, or culture; focus on [a] distinct problem within a specific context 
among a small group of people” (p. 291), may be particularly suitable for the study of 
vulnerable, stigmatized groups and sensitive issues (Li, 2008; Stahler & Cohen, 2000). The 
topics of inquiry for a focused ethnography are pre-selected, and the short-term yet time-
intensive nature of observations are conducive to the study of sensitive topics and complex issues 
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such as substance use disorders in women during the perinatal period within the limitations 
imposed by dissertation studies.  
This study is being conducted at a large tertiary care hospital serving the northern two-
thirds of a state in the northeastern United States. This encompasses a relatively large geographic 
range, with towns located in the farthest reaches of the service region situated well over 100 
miles from the hospital. The area is also identified as having the lowest population density and 
highest rates of poverty in the state, one of the highest rates of opiate addiction in the country, 
and a Native American population greater than five times the national average. These variables 
have previously been noted to be barriers to access to adequate resources for substance use 
disorder recovery, pregnancy, and parenting support. The majority of pregnant women with 
substance use disorders in the area deliver their babies at this hospital. Three smaller hospitals 
located 50 to 100 miles from the hospital provide obstetric services but do not provide care for 
unstable substance-exposed newborns; newborns delivered at one of those small hospitals, either 
anticipated or unplanned, who show signs of neonatal abstinence syndrome in need of escalating 
medication-assisted treatment are transferred. Depending on the circumstances, the mother may 
or may not be transferred with the newborn; typically, the mother has been discharged from the 
hospital and must travel to visit the hospitalized newborn. 
 I engaged in preliminary exploration which provided background information to guide 
this study. Telephone conversations and personal meetings with various providers of care for 
these women as well as attendance at conferences and meetings where these individuals have 
spoken contributed to a greater awareness of the problem. These care providers identified 
potential sites for observation and processes for gaining access to informants in addition to 
anticipated challenges. The relationships cultivated with these professionals has enhanced my 
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ability to conduct the proposed study. This pre-fieldwork yielded what Hammersley and 
Atkinson (2007) termed a foreshadowed problem, the starting point for an investigation that will 
evolve as knowledge is gained through inquiry and observation. 
 This study is currently in progress; to date, primarily due to the recruitment challenges, 
only 13 participants have consented to interviews, observations, and data collection. The original 
prenatal recruitment method, as outlined below, yielded less than half of these participants; the 
remainder have been recruited postpartum through the hospital social worker subsequent to 
protocol amendment. Data in the form of transcribed interviews, participant observation, field 
notes, demographic data, and artifact reviews has undergone preliminary analysis and initial 
coding. Deeper analysis is currently underway and will involve constant comparison to create 
substantive (descriptive) and theoretical (abstract) categories. Data matrices will be developed 
from the coding schema to organize and display categories and establish emerging themes.   
Recruitment Challenges 
Multiple Processes for Ethical Approval 
 To conduct this study, ethical approval from several Institutional Review Boards 
(IRBs) was required, a process that took nearly eight months. IRB members, particularly at the 
study hospital, were concerned about maintaining privacy of the women during prenatal 
recruitment since special protection is required for research involving pregnant women, fetuses, 
and neonates (Protection of Human Research Subjects, 2001). After multiple protocol revisions 
and two full hospital IRB reviews, it was agreed that a researcher-designed informational flyer 
would be made available to eligible women in the perinatal practices. Women interested in the 
study would give permission for me to be contacted by the hospital social worker after delivery 
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to initiate informed consent, Health Insurance Portability and Accountability Act (HIPAA) 
Privacy release, and subsequent data collection. 
 The ethical approval process itself required a certain degree of gatekeeping, consistent 
with the findings of Walker and Reed (2011). The university IRB requested letters of agreement 
from the four perinatal practices to allow and participate in recruitment; the hospital also needed 
to provide a letter of agreement for the study to be conducted, separate from their own IRB 
approval process. For a variety of reasons, it took over three months to receive the letters.  
 As noted by Walker and Reed (2011), gatekeepers of ethical approval for research in 
vulnerable populations and sensitive subjects can serve as facilitators and barriers for the 
protection of their organizations and participants. Reviewers of the original study protocol 
requested that researcher-developed fact sheets for gaining verbal consent by hospital personnel 
and participants’ family and friends for observation during data collection be eliminated, 
deeming them confusing and unnecessary. The hospital’s IRB, however, expressed concern with 
the absence of a verbal consent process for non-participant observations, so the fact sheets were 
reinstated. Additionally, the method of distribution of the research information flyer at the 
perinatal practices evolved with each IRB review. The first reviewers were uneasy with the idea 
that eligible participants would be identified and given a flyer by practitioners due to negative 
experiences reported during previous full IRB protocol reviews, the details of which were not 
disclosed. They suggested instead that recruitment materials with researcher contact information 
be placed in waiting areas and examination rooms. The hospital IRB, on the other hand, disliked 
that procedure and asked that practitioners hand-deliver to eligible women the recruitment flyer 
with a pre-addressed stamped envelope for return to me. The recruitment process, therefore, 
came full circle. 
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 The extended process for ethical approval as well as the time lapse between perinatal 
practice site commitment, subsequent initiation of recruitment, and postpartum data collection 
appear to have negatively impacted recruitment. As will be noted, practitioners seemed to forget 
recruitment procedures, eligibility criteria, or the study itself, or lose the recruitment materials. 
Additionally, the reliance on busy practitioners to facilitate recruitment due to privacy concerns, 
rather than direct recruitment by the researcher, may also reduce the potential participant pool. 
Lack of time and gatekeeper bias toward participants deemed more reliable or favored in some 
way may also skew the participant pool. My experience is consistent with challenges noted by 
Bonevski et al. (2014) and Namageyo-Funa et al. (2014).   
Ineligibility 
 One inclusion criterion for the study is a personal substance use history inclusive of 
opioids, whether that be past or current use of illicit substances, misuse of prescription opioids, 
or engagement in opioid-replacement therapy, in recovery or relapsing. Several of the women 
who returned flyers early in the process did not in fact have a personal substance use history. 
They indicated that they misread or misunderstood the criteria for inclusion in the study and 
thought having a friend or relative with a substance use history would qualify them.  
Women to be considered for the study also need to be currently pregnant since informed 
consent and data collection commences once the woman delivers her baby. Several women 
returning flyers, when asked about their expected due dates, responded that they had delivered a 
number of months prior. This discovery illuminated a limitation of the study which did not allow 
access to women once they and their baby were discharged from the hospital. 
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Unavailability 
Given the demographic profile of the women most likely eligible for the study (rural, 
higher rates of poverty, relapsing nature of substance use disorder), it was not surprising that I 
was never able to reach three of the women who returned flyers despite multiple attempts. This is 
not an unusual phenomenon (van Wijk, 2014). Wireless coverage in the northern part of the state 
is often unreliable. Residents turn to web-based service and prepaid phones for numerous 
reasons. Economic instability may cause unpaid bills and disconnected service. Lapses in 
judgment and avoidance of law enforcement also may result in full voice mailboxes and 
unreturned calls. In one case, the message on every attempt was “number unreachable.” Multiple 
voice messages left over a period of weeks, with the other two potential participants, were never 
returned. 
Practice Change 
 When the study was initially proposed, all babies born with any addictive substance 
exposure in the northern part of the state were automatically transferred to the large hospital 
where the study was approved. In the time between study proposal, IRB approval, and 
commencement of recruitment, practices at the smaller hospitals evolved. Substance-exposed 
babies not requiring pharmacologic treatment were being retained for observation at the small 
hospitals. One of the earliest flyers I received was returned by a woman whose first baby 
required transfer for observation and treatment; she was hopeful that this delivery would be 
different. Indeed, as it turned out, she and her baby were able to stay in their local community 
hospital, which was a positive outcome for them but the loss of a study participant.  
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Observed Anomalies 
 The recruitment flyers were color-coded by perinatal practice site to facilitate data 
collection and organization. I supplied what should have been sufficient numbers of flyers and 
pre-addressed stamped envelopes to each practice with the promise of more as needed. I 
maintained close contact with each practice to check on the status of the supply of flyers. Several 
months into recruitment, white flyers in envelopes not provided by me began to appear, some 
with stamps that had not been cancelled and appeared to have been left in my mailbox without 
going through the postal service. This was a bit unsettling, as I live well over 100 miles from the 
hospital and nearest perinatal practices. Coincidentally, all but one of those irregular returns were 
also from women with whom I could not connect. I again contacted the practitioners to reinforce 
the recruitment process, and the anomalies ceased.  
Questionable Leadership Approval 
 After months of recruitment, I noticed that one of the recruitment sites had not yet 
yielded a returned flyer. This might not be unusual given that it is a small rural perinatal practice; 
however, the rate of perinatal substance use disorder in that county is among the highest in the 
state. Additionally, the senior administrator who had granted permission for recruitment was no 
longer at the hospital and the remaining administrators were unaware of the study, a finding that 
was revealed when I sought an amendment to the original study proposal. Unfortunately, this 
experience seemed to create enough uncertainty that the new senior administration elected to 
prohibit further recruitment efforts. 
Recruitment Facilitators 
I initially contacted perinatal practice leadership to delineate the research purpose and 
plan to conduct the study with women in their service area. Hammersley and Atkinson (2007) 
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identify individuals with control over access to key informants or potential participants as 
gatekeepers and suggest that “identifying the relevant gatekeepers is not always straightforward” 
(p. 49). It has been noted that most health-related research studies of human participants involve 
collaboration with other health care professionals, and cultivating relationships with key 
administrative, clinical, and support staff is crucial to successful recruitment at the practice sites 
(Patel, Doku, & Tennakoon, 2003; van Wijk, 2014). I connected with the practice leaders 
through the process of community networking as described during preliminary work; often the 
support staff facilitated introductions with practice leaders. Leadership positions ranged from 
practice manager to hospital senior administration to health care practitioner. I then arranged 
initial meetings with the practitioners designated to identify potential informants and facilitate 
recruitment. I have attempted to maintain ongoing dialogue with these practices through personal 
meetings, e-mail, and telephone communication to further cultivate the relationships. This 
relationship-building has proven to be beneficial to the recruitment and data collection process. 
 I was aware of the potential constraints and limitations posed by study of a vulnerable 
rural population, including distance, time constraints, fluctuations in women meeting inclusion 
criteria, their availability and willingness to participate, and attrition. The relationships fostered 
with perinatal practitioners have mitigated the challenges, but my willingness to remain flexible, 
sensitive, and responsive to practitioner and participant needs has been equally important.  
Conclusions and Lessons Learned 
 Conversations about the recruitment challenges with my advisor and the hospital social 
workers led to possible strategies to improve the recruitment process. The hospital social workers 
suspected many eligible participants were not being identified through the perinatal practices due 
to practitioner time constraints and confusion regarding the process, which is consistent with 
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other reports in the literature (Namageyo-Funa et al., 2014). They suggested direct recruitment in 
the hospital and were willing to act as facilitators since they were already familiar with the study 
and the population. Subsequently, amendments to the original study proposal were approved by 
the IRB, and two participants have been recruited into the study. 
 Qualitative research takes time which can result in changes in practice patterns 
(Hammersley & Atkinson, 2007) and which was certainly the case in the present study. The 
revelation that the small rural hospitals were changing practice and beginning to retain 
substance-exposed newborns for observation unless pharmacologic treatment was needed 
motivated me to seek an additional protocol amendment to allow direct recruitment and data 
collection at those rural hospitals. The IRB has approved the amendment and I have met with 
senior hospital leadership and the perinatal unit nursing staff to initiate the process. A parallel 
process was advancing slowly through the other rural hospital where a complete senior 
leadership turnover has occurred and the original administrative approval was in question. I have 
spent countless hours meeting in person and by conference calls with the current administration 
to establish legitimacy and regain trust so the study may advance, to no avail. 
 A prior study by Namageyo-Funa et al. (2014) identified recruitment challenges, 
including access to participants with the use of one recruitment strategy and limited interview 
locations. These issues have become evident in the current study. The distribution of flyers 
through gatekeepers at multiple sites, with diverse practices and processes, and the restriction of 
data collection to the inpatient postpartum setting, seem to have undermined recruitment rather 
than enhanced it. I anticipate that expansion of the study to the small rural hospitals may mitigate 
some of those constraints. I did contact a number of substance use disorder treatment practices in 
the service area on the advice of the social workers; they hypothesized that, although pregnant 
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women may receive integrated services for pregnancy and substance use, some women may slip 
through the cracks and be more easily recruited through a substance abuse program. Those 
practitioners politely declined to participate, indicating that they did not feel they could add to 
the current recruitment efforts. In consideration of the potential participants excluded due to lack 
of personal substance use history but who had friends or relatives with substance use disorders, I 
am now offering additional flyers and envelopes to study participants to share with contacts who 
may be interested. As indicated by several potential participants who were excluded due to 
remote delivery and hospital discharge dates, the ability to collect data in the postpartum period 
following hospital discharge may have further augmented informant recruitment. Although this 
strategy was considered in the original study proposal development, it was rejected for 
consideration of my safety. In hindsight, I would have contemplated other creative solutions, 
such as data collection at the same perinatal practices in the postpartum period rather than at 
private homes or other public places.  
  As noted by Maxwell (2013), the exploratory nature of ethnographic research requires a 
focused yet flexible approach to sampling and data gathering, which extends to participant 
recruitment and negotiating of relationships. Maxwell further asserts that “research 
relationships…can facilitate or hinder other aspects of the research design” (p. 91), and 
gatekeepers are included in the established relationships. Despite careful forethought and 
planning, I encountered numerous challenges in the recruitment process alone. It is hoped that 
through this reflection and reconsideration of methodological decisions, other qualitative 
researchers might avoid and be prepared for similar challenges. Persistence in overcoming 
barriers to inclusion of already marginalized and underrepresented populations in research 
studies may significantly impact their outcomes. 
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CHAPTERS 5 AND 6 
Chapters 5 and 6 comprise the final study findings and discussion in manuscript form for 
submission for publication to Qualitative Health Research.  
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Abstract 
Perinatal opioid use and neonatal withdrawal continue to rise rapidly in the face of the 
growing epidemic of opioid addiction in the United States, with rural areas more severely 
impacted. Despite several decades of research and development of practice guidelines, maternal 
and neonatal outcomes have not improved substantially. Through the voices of 13 rural women, 
this focused ethnography sought to better understand the experience of accessing treatment and 
care necessary for substance use disorder recovery, pregnancy, and parenting. Their personal 
accounts, reinforced by participant observation and artifact review, uncovered three domains 
with underlying themes: challenges of getting treatment and care (service availability, 
distance/geographic location, transportation, provider collaboration/coordination, physical and 
emotional safety), opportunities to bond (proximity, information), and relationships (respect, 
empathy, familiarity, inclusion, interactions with care providers). The findings highlight the need 
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for providers and policy makers to reduce barriers to treatment and care related to logistics, 
stigma, judgment, and lack of understanding of perinatal addiction. 
Background 
The United States is facing an escalating epidemic of opioid addiction. Since 1999, sales 
of prescription opioid analgesics and the rate of unintentional opioid-related overdose deaths 
have more than quadrupled, with women being affected more than men, disrupting the health, 
social, and economic welfare of the country (American Society of Addiction Medicine [ASAM], 
2016; Senate Caucus, 2014; United States Department of Health and Human Services [HHS], 
2016). Additionally, emergency room visits for nonmedical prescription opioid use increased by 
183% from 2004 to 2011, and there was a 900% increase in individuals seeking treatment for 
prescription opioid addiction from 1997 to 2011 (Kolodny et al., 2015; Substance Abuse and 
Mental Health Services Administration [SAMHSA], 2013). The opioid epidemic has been 
accompanied by a sharp rise in perinatal exposure to opioids and subsequent increase in the 
incidence of neonatal abstinence syndrome from 1.5 to 6.0 cases per 1000 hospital births from 
1999 to 2013 (Ko et al., 2016; Patrick et al., 2015; Pryor et al., 2017; Tolia et al., 2015). Data 
show disproportionately higher rates of perinatal substance use in rural areas, with three states 
(Maine, Vermont, and West Virginia) experiencing greater than tenfold increases and NAS 
incidence rates > 30 per 1,000 hospital births (Ko et al., 2016; Villapiano, Winkelman, 
Kozhimannil, Davis, & Patrick, 2016).  
Neonatal abstinence syndrome (NAS) is a term used to describe the postnatal opioid 
withdrawal that may occur in up to 94% of newborns prenatally exposed to prescription or illicit 
opioids used by a woman during pregnancy (McQueen & Murphy-Oikonen, 2016). This statistic 
has been questioned due to the variability in identification of NAS as well as the influence of 
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factors such as polysubstance exposure, timing and level of exposure, and social determinants of 
maternal health (Clark & Rohan, 2015; Tolia et al., 2015). Clinical manifestation of NAS are 
related to dysregulation and hyperirritability of the central and autonomic nervous, respiratory, 
and gastrointestinal systems and can range from mild tremors and irritability to excessive weight 
loss and seizures (McQueen & Murphy-Oikonen, 2016; Sublett, 2013). Symptoms, which 
generally appear within the first five days of life, are treated with a combination of 
pharmacologic and non-pharmacologic therapies (swaddling, rocking, dark quiet room, pacifier) 
which have historically required specialized care in the neonatal intensive care unit (NICU). In 
one large national data set, the median length of hospital stay for NAS was reported to be 19 
days (Tolia et al., 2015). Studies have suggested that excessive prenatal substance exposure may 
result in negative birth outcomes, including low birthweight and prematurity (Walton-Moss, 
McIntosh, Conrad, & Kiefer, 2009), delayed cognitive and motor development (Mactier, 2013), 
and increased child protective involvement (Lean, Pritchard, & Woodward, 2013), placing an 
even greater burden on health care, social welfare, and foster care services. In short, perinatal 
opioid use is a significant and costly public health issue (Patrick et al., 2012).  
Perinatal substance use directly impacts both the woman and her developing child, and 
attempts to identify variables that may be predictive of neonatal outcomes have produced 
conflicting results. Studies have failed to demonstrate a predictable correlation between duration, 
timing, and total cumulative dose of prescription opioids on incidence or severity of NAS (Desai 
et al., 2015; Kraft, Stover, & Davis, 2016; Stover & Davis, 2015). A singular focus on drug type 
and dose seems unable to account for the complex array of factors contributing to neonatal 
outcomes. Additionally, no definitive evidence exists that opioid exposure alone results in 
negative long-term developmental outcomes in children; adverse childhood experiences and 
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toxic stress, which includes health disparities related to poverty and rurality, contribute to poor 
outcomes and may be mitigated by access to treatment and care (Holbrook & Nguyen, 2015; 
Shonkoff & Garner, 2012; Sword et al., 2009). 
Studies focusing on care of the newborn with neonatal abstinence syndrome have been 
equally inconclusive. This is likely due, in part, to wide variations in care of opioid-exposed 
newborns and lack of standardized NAS treatment (Bogen, Whalen, Kair, Vining, & King, 2016; 
Kelly et al., 2016). Factors other than maternal medication-assisted treatment, such as maternal-
infant bonding, seem to influence neonatal outcomes. Maternal-infant bonding has been 
described as an affective process with behavioral and biological indicators (Altaweli & Roberts, 
2010; Bicking Kinsey & Hupcey, 2013). Breastfeeding and rooming-in during the immediate 
postpartum period has been found to promote bonding (Altaweli & Roberts, 2010), while 
physical or emotional separation of the mother from the newborn can inhibit bonding (Bicking 
Kinsey & Hupcey, 2013). Increased parental presence at the newborn’s bedside has been shown 
to increase rates of breastfeeding, reduce need for pharmacologic treatment, shorten duration of 
treatment, and decrease length of hospital stay (Cirillo & Francis, 2016; Hodgson & Abrahams, 
2012; Hünseler, Brückle, Roth, & Kribs, 2013; Newman et al., 2015).  
Early and adequate prenatal care has been shown to alleviate negative effects of 
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning, 
2012). Reduction of physical and psychological barriers to women’s access to adequate care is 
necessary to promote engagement (Lefebvre et al., 2010; Saia et al., 2016). Studies of early 
identification, engagement, and treatment retention of pregnant women using integrated 
substance abuse and perinatal services are demonstrating potential benefits in the promotion of 
maternal-infant bonding (Meyer et al., 2012; Taylor et al., 2012). Harm reduction approaches 
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combined with comprehensive care models (antenatal care, social services, and substance use 
treatment) are also showing promising results, such as increased prenatal care visits and patient 
satisfaction, improved coordination of care, and decreased drug and alcohol use (Goodman, 
2015; Lander, Marshalek, & Sullivan, 2016; Marcellus, MacKinnon, Benoit, Phillips, & Stengel, 
2015; Nathoo et al., 2015; Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, & 
Boyajian, 2013). These programs have been found to be feasible, yet they are resource-intensive 
and are often located in urban academic medical settings (Mittal & Suzuki, 2015). While access 
to integrated care models may be limited in rural areas, coordination of community-based 
services is possible with careful planning (Jumah, Graves, & Kahan, 2015; Meyer & Phillips, 
2015). The principles of harm reduction include strategies for reduction of the negative impact of 
substance use as well as advancement of the rights of people who use substances (Harm 
Reduction Coalition, n.d.). Such a philosophy requires care providers to set aside their own 
opinions and emotions regarding substance use and instead focus on re-engagement of the 
woman moving forward (Bartlett, Brown, Shattell, Wright, & Lewallen, 2013).  
Programs for perinatal substance use disorders described in the literature have used a 
variety of interventions, including integrated prenatal and substance abuse services and 
motivational incentives (Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, & 
Boyajian, 2013). Additionally, women and providers may perceive effectiveness of program 
components differently, so it is unclear which aspects of a harm-reduction approach contribute to 
outcomes (Kruk & Sandberg, 2013). A focused review of the literature, highlighting studies of 
perinatal substance use disorders that included health care provider-mother-infant relational 
perspectives within various care delivery models, concluded that published studies have yet to 
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identify the relative contribution of multiple risk factors to adverse outcomes as well as program 
components most likely to improve outcomes (Kramlich & Kronk, 2015).  
Pregnancy is often the impetus a woman needs to seek treatment for substance use 
disorder, providing an opportunity for health and social care providers to engage these women 
(Krans, Cochran, & Bogen, 2015). Covington (2008) suggested that women-centered approaches 
to addiction and recovery should be gender-responsive, focusing on fostering connection 
between healthcare providers and the women. She described a model of integrated care for 
women framed in part by relational-cultural theory, which emerged from the work of Jean Baker 
Miller in the 1970s (Comstock et al., 2008). Relational-cultural theory posits that healing 
relationships are contextual, grounded in cultural and social identity, and that fear, shame, and 
mistrust challenge the development of connection (Comstock et al., 2008).  
Identification of maternal substance use and engagement in treatment have been found to 
be challenging. Research has shown continued misunderstanding and negative attitudes of 
healthcare providers toward pregnant women with substance use disorders (Benoit et al., 2014; 
Maguire, Webb, Passmore, & Cline, 2012; Murphy-Oikonen, Brownlee, Montelpare, & Gerlach, 
2010). Pregnant women with substance use disorders may delay or completely avoid seeking 
substance use treatment due to fears of judgmental or uncivil care provider reactions (Metz, 
Kochl, & Fischer, 2012). Some studies have indicated that universal screening of all women for 
drugs and alcohol may reduce socioeconomic and racial disparities, resulting in improved 
identification (Casper & Arbour, 2013; Eichel & Johannemann, 2014; Roberts & Nuru-Jeter, 
2011), while others have suggested that fear of negative consequences related to discovery may 
preclude women from seeking prenatal care (Roberts & Nuru-Jeter, 2010). Societal stigma, low 
literacy levels, socioeconomic constraints, lack of resources, and rural healthcare disparities, 
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specifically those related to poverty, further complicate engagement  and access to treatment and 
contribute to the negative outcomes for both mother and child (Alto & O'Connor, 2011; Jumah, 
2016; Lander et al., 2013).  
Social determinants of health, defined by the World Health Organization (WHO) as “the 
conditions in which people are born, grow, work, live, and age, and the wider set of forces and 
systems shaping the conditions of daily life” (WHO, 2017, para. 1), have been shown to impact 
both substance use and perinatal outcomes (Centers for Disease Control and Prevention [CDC], 
2011; Kim & Saada, 2013). Women living in rural areas tend to have lower rates of early 
initiation of prenatal care, higher rates of pregnancy complications, and higher infant mortality 
rates than their urban counterparts, even when controlling for substance use (American College 
of Obstetricians and Gynecologists [ACOG], 2014). Additionally, socioeconomic disparities, 
such as poverty, unemployment, and low education level, which are more prevalent in rural 
areas, are associated with late or inadequate prenatal care and higher rates of adverse birth 
outcomes (ACOG, 2014; Blumenshine, Egerter, Barclay, Cubbin, & Braverman, 2010; Phillippi, 
2009). Access to prenatal care in rural areas is often hindered by lack of resources (finances, 
transportation, childcare, availability); in women with substance use disorders, these barriers are 
compounded by fear of judgment and losing child custody (Phillippi, 2009). Rural areas are also 
much less likely to have adequate outpatient substance use disorder treatment services 
(Cummings et al., 2014). Such barriers to treatment for pregnant women related to limited 
accessibility and availability have been identified nationally (Jumah, 2016; Krans & Patrick, 
2016). 
The issue of maternal substance use and its negative impact on both the mother and the 
infant persists despite numerous studies from multiple perspectives. Published studies have yet to 
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identify the relative contribution of multiple risk factors to adverse outcomes as well as program 
components most likely to improve outcomes. The voice of pregnant and parenting women with 
substance use disorders seems to be largely missing in the literature as evidenced by the 
comparatively limited number of qualitative studies. This focused ethnography aimed to address 
that gap by exploring rural women’s experiences and perceptions of care to inform development 
of efficacious, holistic models of care to improve outcomes for these women and their children. 
Design and Method 
As noted by Woodley and Lockard (2016), qualitative research methods may provide 
more opportunities to engage with marginalized groups through personal connections as 
compared to quantitative methods, therefore informing the choice of study design. Focused 
ethnography, defined by Munhall (2012) as “the study of small elements of one society, group, 
or culture; focus on [a] distinct problem within a specific context among a small group of 
people” (p. 291), was particularly suitable for this study. The topics of inquiry for a focused 
ethnography are pre-selected, and the short-term yet time-intensive nature of observations are 
conducive to the study of sensitive topics and complex issues such as substance use disorders in 
women during the postpartum period. Participant observations, oral accounts, and formal 
interviews were used, with artifact review (media documentation of the sociopolitical 
environment influencing the women’s care) woven into this data, to better understand: (1) the 
experiences and perceptions of postpartum women with substance use disorders regarding the 
care they received during their pregnancy and through their infants’ hospitalization; and (2) how 
have their experiences supported or inhibited their ability to bond with their baby. 
This study was conducted at a large tertiary care hospital serving the northern two-thirds 
of a state in the northeastern United States, an area encompassing seven counties and nearly 
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25,000 square miles. The majority of these counties are identified as rural as defined by the 
Federal Office of Rural Health Policy (Health Resources & Services Administration, 2017). 
Towns located in the farthest reaches of the service region are situated nearly 200 miles from the 
hospital. This area is known to have one of the highest rates of opiate addiction in the country, 
with over 12% of live births identified as substance-exposed (Hayes & Brown, 2012; Ko et al., 
2016). The area is also identified as having the lowest population density and highest rates of 
poverty in the state and a Native American population greater than five times the national 
average (Maine Center for Disease Control and Prevention, 2103; Maine Department of Health 
and Human Services, 2008; Maine State Planning Office, 2012), factors noted to be barriers to 
access to adequate resources for substance use disorder recovery, pregnancy, and parenting 
support (Center for Substance Abuse Treatment [CSAT], 2009). 
Institutional Review Board (IRB) approval was granted by the hospital to conduct formal 
interviews with participants, informal conversations with non-participants, and observations of 
the care environment and processes. Letters of agreement for participant recruitment were 
obtained from directors of agencies and practices where potential informants were to be 
recruited. Women were recruited for study participation in two ways, either through 
informational flyers shared by their prenatal providers or by the inpatient perinatal social 
workers after delivery. Women were offered a $25 gift card to a local department store to 
participate in the study, received upon completion of the formal interview and data collection. 
Written informed consent was obtained from participants upon initial contact and reaffirmed 
verbally with any subsequent interaction. Health Insurance Portability and Accountability Act 
(HIPAA) release was also obtained prior to review of any agency records. Information sheets 
explaining the study were distributed to all staff involved in the care of the prospective 
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informants. Verbal consent, supplemented with information sheets, was obtained from persons 
not directly involved in the study but who became part of the data collection through their 
interaction with prospective informants (such as friends and family members).  
Women to be included in the study must have been pregnant (if recruited through 
prenatal practices) or have recently given birth (if recruited through inpatient perinatal social 
workers); English-speaking; at least 18 years of age and able to give informed consent; and had 
an identified substance use disorder that included current use of an opioid (legally prescribed 
medication assisted treatment, misuse of prescription opioid medications, or illicit opioids). A 
total of 22 referrals were received over a 10-month period; of those potential participants, five 
were deemed ineligible due to lack of personal history of substance use or already having 
delivered their baby. Four other women were never successfully contacted due to unreachable 
phone numbers, unreturned messages, or full voice mail-boxes despite multiple attempts. One 
potential participant, whose first baby was transferred to the tertiary care hospital from a small 
rural hospital, anticipated transfer of her second baby after delivery, as well. The practice 
changed, however, and her baby was retained for observation at the small hospital, therefore 
exempting her from participation.  
Thirteen women were subsequently consented and interviewed, ranging in age from 22 to 
40 years, with diverse demographics in terms of race/ethnicity, relationship status, child custody, 
and stage of addiction recovery (Table 1). Nine of the interviews were conducted shortly after 
delivery, during the five-day NAS observation period, with the remainder conducted nine days to 
five weeks postpartum while the infants were receiving pharmacologic therapy for NAS. Only 
about half of the women described living in stable housing with their partner and any other 
children. Five of the women were living with extended family or friends, one temporarily. Six of 
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the state’s 16 counties were represented, covering a geographic area of approximately 20,000 
square miles, more than half of the state. Ten of the 13 women were multiparous and were 
therefore able to compare their current experiences with those of previous pregnancies. Five 
women had one or more psychiatric diagnoses that included depression (5), anxiety (4), bipolar 
disorder (4), and post-traumatic stress disorder (2); three of those women had also been 
diagnosed with attention-deficit/hyperactivity disorder. 
Semi-structured interviews were conducted by the principal investigator in the mother’s 
or baby’s hospital room and typically lasted 30 to 40 minutes. An interview guide, adapted from 
Spradley (1979), was used to start with broad, open-ended grand tour questions focusing on 
treatment and care received during pregnancy and eventual hospital experiences; subsequent 
questions were based on answers to the grand tour questions. Interviews were digitally audio-
recorded and transcribed verbatim by the researcher. Observations ranged from broadly 
descriptive of the general hospital environment to more narrowly focused and selective during 
participant interviews and were recorded through handwritten fieldnotes. The researcher was 
denied access to the full electronic health record, so limited demographic data were gathered 
from existing paper records. Other material artifacts, such as informational literature and 
educational brochures that may have been relevant to the study, were not found in public areas. 
Visual media reporting on the impact of perinatal substance use was collected and served to 
augment the formal interviews and observations. All protected health information was de-
identified and each case was assigned a computer-generated random code which was used on all 
digital files, transcripts, fieldnotes, and journal notes to maintain participant confidentiality. 
Informed consent and HIPAA forms were stored separately from interview transcripts and all 
other forms of data. 
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Framework analysis was used to analyze all data, including transcripts, typed fieldnotes, 
and material artifacts, using various functions in Microsoft® Word, aided by NVivo 11® 
computer-assisted qualitative data analysis software. Data analysis proceeded according to the 
stages of framework analysis as described by Ritchie and Spencer (1994). 
Stage 1: Familiarization through immersion in the data 
Prior to transcription, recorded interviews were listened to for elements of speech, such 
as intonation, stress, tempo, rhythm, pause, pitch, and register. Typed fieldnotes and 
transcriptions were reviewed and proofed against handwritten and recorded data for accuracy and 
served as preliminary analysis to guide subsequent data collection and analysis. Transcripts and 
fieldnotes were read completely several times to get a sense of the whole (Sandelowski, 1995). 
Digital and material artifacts, such as news accounts, were also gathered and reviewed for 
relevance to the study. Jottings in margins served to create initial potential codes. 
During this stage of familiarization, initial random coding of the interview transcripts 
revealed 25 emerging concepts. Phrases exemplifying the concepts were extracted from the 
transcripts and served as a catalyst for identification of a thematic framework. A key word count 
was conducted using the “find” function in Microsoft® Word; dictionary definitions aided in 
identification of synonyms and reduced the list from 25 to 13 concepts. Eighteen theoretical and 
philosophical approaches to care in this population, informed by the literature review, pre-
fieldwork conducted by the researcher, and consultation with the dissertation committee chair 
and external member topic expert, were considered in the development of the thematic 
framework (Stage 2). 
 
 
  125 
Stage 2: Identification of a thematic framework 
As noted by Pope, Ziebland, and Mays (2000), “key issues, concepts, and themes by 
which the data can be examined and referenced [are identified] …by drawing on a priori issues” 
(p. 116). In this stage, findings from the literature and pre-fieldwork conducted by this researcher 
guided development of a thematic framework. Theoretical constructs and themes identified in 
previous studies were used to develop labels for subsequent data categorization, the researcher’s 
“etic” interpretation of the data. 
Five theoretical and philosophical approaches were culled from the initial list based on 
the congruence of the theoretical constructs with the emerging concepts. Through an iterative 
process of comparing the terminology between the theoretical constructs and the emerging 
concepts, three of the approaches, harm reduction, relational-cultural theory, and maternal-infant 
bonding, surfaced as a sufficient thematic framework to categorize the data. Subsequently, a 
codebook was created to begin Stage 3, the process of indexing the data. 
Stage 3: Indexing – thematic framework applied to the data in text 
Index headings were created from the thematic framework and then applied to units or 
segments of data that appeared significant or relevant. Passages of data were highlighted and 
color-coded notes were made in the margins of transcripts, fieldnotes, and print artifacts. 
Annotations and analytic memos assisted with this process and subsequent comparison within 
and between cases. 
Stage 4: Charting through data matrices 
Data matrices were developed from the coding schema to organize and display 
categories. Substantive categories reflect the “emic” view, informant perspectives in their own 
words taken from recorded data. Abstraction and synthesis of verbatim text was then 
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summarized and passages were entered into charts to assist with subsequent mapping and 
interpretation. 
Stages 3 and 4 (Indexing and Charting) proceeded almost simultaneously; as the 
transcribed and artifact data were reexamined through the lens of the coding themes, data 
matrices and summary charts were developed. Concurrently, a list of initial impressions was 
developed to solicit feedback from the ten participants who consented to being contacted after 
the culmination of data collection. From that list, a feedback letter to participants was created in 
a more readable and welcoming format. This process assisted in further refinement of the 
themes, as it became apparent that both facilitators and barriers or challenges existed within each 
of the themes.  
Stage 5: Mapping and interpretation to find patterns, relationships, and explanations 
The data matrices were further reviewed for themes and searched for patterns and 
possible explanations for barriers to and facilitators of care in this population. The original aims 
of the study and concepts generated from the data influenced this process, as suggested by Heath 
et al. (2012). 
Validity of the data, also known as trustworthiness, authenticity, and credibility, was 
addressed through strategies described by Maxwell (2013). The principal investigator has 
experience with the population of interest but was relatively unfamiliar with the study setting, 
which may have reduced any researcher bias. Additionally, a reflective journal served to both 
document analytic decisions and identify possible personal biases. Data was collected from a 
variety of information sources (interviews, observations, artifacts) to build justification of 
themes; documentation and analysis of that data contained thick, rich description. Data matrices 
developed for data retrieved from all sources were shared with the dissertation committee chair, 
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and discussions with the chair and methods expert assisted in validation of impressions and 
search for any negative or discrepant information. Ten of the 13 women consented to follow-up 
after discharge; a member checking letter was sent to those 10 women, with only one response, 
and she concurred with the findings. Informational redundancy was recognized by the tenth 
interview; three additional interviews produced no new themes, and therefore data saturation was 
reached.  
Findings 
Participants described both supportive and challenging care experiences they encountered 
for their substance use disorder, their pregnancy, and their subsequent delivery and participation 
in their baby’s care. Their experiences and perceptions of care uncovered three domains with 
underlying themes: challenges of getting treatment and care (i.e., service availability, distance 
and geographic location, transportation, collaboration and coordination among providers, 
physical and emotional safety), opportunities to bond (i.e., proximity, information), and 
relationships (i.e., respect, empathy, familiarity, inclusion, interactions with care providers).  
Challenges of Getting Treatment and Care 
 This domain focuses on the women’s narratives of the challenges they encountered in 
seeking substance use disorder treatment and pregnancy care; arranging and getting to 
appointments once they did find treatment and care; and dealing with multiple providers, often in 
separate locations. The women also recounted situations that helped them overcome any personal 
and logistical challenges they might have faced. The harm reduction literature provided a 
framework for themes that emerged within this domain.  
Waiting to get treatment. The 13 women interviewed shared numerous challenges to 
accessing treatment, most notably with respect to availability of providers, compounded by 
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distance, transportation, and coordination of services. Five of the 13 women spoke of the 
challenges to access to treatment related to the lack of available services, insurance issues, and 
long waitlists. Three of these women had been trying to get into substance use disorder treatment 
for months; they gained immediate access once they became pregnant because they were then 
Medicaid eligible. As one woman noted, “you had to wait”; another stated, “it was impossible to 
get anywhere, and as soon as I got pregnant I got everything I possibly could need.” The third 
woman became incarcerated during a six-month waiting period; she did not discover her 
pregnancy until several months into her incarceration, and then she could not receive treatment 
until she was released several weeks later. The three other women sought treatment early in their 
pregnancies, and their access was expedited, as exemplified by the comment “I was the first one 
they called because I was pregnant.” Expedited access due to pregnancy, however, did not 
mitigate the lack of available treatment options; neither the one inpatient facility nor the handful 
of outpatient services in the northern part of the state offered women-specific therapy. Only one 
integrated program for pregnant and parenting women, with specialized substance use disorder 
treatment, mental health, and social services co-located within a perinatal care practice, was 
available in this area. 
Geographic location is hard. Six of the 13 women lived in the county where the hospital 
and most services are located; the remainder traveled up to three hours for their appointments. 
Barriers presented by distance and geography (remote rural areas, only 10% of the state’s public 
roads are major roads, many in poor condition) are illustrated by the comment “living an hour 
away is definitely hard.” Women who received separate substance use disorder treatment and 
perinatal care services in different locations faced additional challenges, regardless of where they 
lived. One woman living in a different county stated that she received her services in “two 
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separate places…it was hard.” Another woman traveled 40 minutes to receive treatment and care 
in two different offices but stated, “it worked out pretty well ‘cause they’re not that far away 
from each other.” The women’s perceptions of any barriers related to distance and location 
seemed to be influenced by other factors, such as transportation and relationships with care 
providers. One woman noted, “I live in [hometown], so it was 45 minutes away, which made it a 
little difficult, but definitely worth it”, while another woman who lived two hours away offered, 
“I do have the option to go somewhere closer to home, but I don’t want to, I really like where I 
am.” Three other women traveled long distances for treatment and care by choice due to lack of 
confidence in providers close to their homes. One woman described feeling “like you’re going 
back 30 years”, while the other two perceived a lack of adequate knowledge and technology.   
Transportation is a struggle. Ten of the 13 women talked specifically about 
transportation issues, such as limited options and variable quality. Due to its rural nature, the 
state’s public transportation system consists of unlinked transit services, a centralized non-
emergency transportation scheduling system for persons with disabilities or low income, and 
reliance on volunteers. Public transportation for these women is typically coordinated by two 
non-profit social service agencies with mixed reliability and convenience. Four of the women 
stated they had no public transportation options, while four others described it as “unreliable.” 
Women described a variety of transportation challenges irrespective of geographic proximity to 
care providers: delays in receiving approval for free transportation and filling the gaps with rides 
from family and friends; arranged transportation that arrived too early, too late, or not at all; 
weather-related transportation cancellations; refusal of city buses to go to one of the substance 
abuse service agencies due to safety concerns; navigating public transportation with small 
children and their gear in tow; and having to pay cab fare home because appointments ran late. 
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As one woman plainly stated, “it’s been a struggle with transportation, especially not having a 
license..., having anxiety and PTSD (post-traumatic stress disorder) not able to take the 
bus…some days, like snowstorms or whatever, they cancel…the bus stops at 6:00…and I would 
have to take a cab home.” Her experience was echoed by another woman who stated, “for 
somebody that couldn’t handle for whatever reason doing [public transportation], what, a cab? 
For me, that’s $3 every time…unfortunately, a lot of my family doesn’t know, so my option is 
taxi.” Two women who were new to the area weren’t aware of available options; one stated she 
didn’t know about [non-emergency transport service], while the other (who lived almost an hour 
away from the hospital and received treatment and care from two practices 40 miles apart) 
wasn’t aware of bus transportation. Since the two women had not established social contacts in 
the area and did not have cars or driver’s licenses, private transportation was extremely limited. 
Despite the challenges, three women expressed relief that they had some form of transportation, 
as conveyed by the statement, “I didn’t have to worry about rides, and [non-emergency transport 
service] was helpful, too, because they made it so I could actually get there.” 
Collaboration and coordination among providers. Six women who received treatment 
and care in separate practices for their substance use disorder and their pregnancy encountered 
varying levels of collaboration and coordination among care providers. Two of the women 
expressed satisfaction with the level of collaboration and coordination between their providers. 
As one stated, “they seemed to coordinate very well”, while another noted that both practices 
worked together to accommodate her schedule. One woman who was told by her long-time 
provider that “if I got pregnant again he couldn’t see me anymore” described being pleasantly 
surprised to discover that he facilitated transfer of her treatment and care to two new providers, 
one with whom she was already familiar; as she said, “I didn’t have to do anything, like he made 
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all the appointments for me, he did all the referrals, he took care of everything…that was 
awesome.” 
Even women who expressed satisfaction with their providers found mixed collaboration. 
For example, one woman indicated that her obstetrician and substance use disorder provider did 
not discuss adjustments of her buprenorphine dosing. She found that her dose had been increased 
due to reported hip discomfort, without her or her obstetrician’s knowledge, stating that her 
provider “just wanted to make sure she was getting through the night OK.” Subsequently, her 
obstetrician would ask “she didn’t change you again, right?” Another woman had a similar 
experience in a different location, where decisions to increase her buprenorphine dose were not 
discussed with her or between her prescriber and her obstetrician, and both providers relied on 
her to relay information between them. One woman described a lack of communication and 
collaboration among obstetric providers within the same practice, noting that lab tests were 
repeated or omitted and the tubal ligation for which she consented with her elective repeat 
Caesarean section was overlooked. A third woman simply stated, “they didn’t really 
communicate (with one another).” 
Coordination of appointments at separate practices was also variable. One woman stated 
that “they seemed to coordinate very well” in scheduling her appointments and found “it wasn’t 
that big of an inconvenience.” Another woman noted that while attempts were made to schedule 
her appointments on the same day, “sometimes that didn’t happen”, while a third woman 
asserted “basically I did it by myself.” 
Seven women received integrated care through a program where specialized substance 
use disorder treatment, mental health, and social services are co-located within a perinatal care 
practice. Care is coordinated by a core group of physicians and an advanced practice nurse. 
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These women expressed great satisfaction with their care, all using words such as “easy” and 
“convenient.” One woman stated that “it made it so much easier, you know, to be able to just go, 
and the same doctor I was seeing for my pregnancy was the same doctor that was prescribing me 
the Subutex.” None of these seven women had previously received both substance use treatment 
and prenatal care where services were not integrated; one woman received prenatal care for two 
prior pregnancies in another state and had not sought substance use treatment, instead actively 
using illicit substances throughout those pregnancies. She did not elaborate on her reasons for 
not previously seeking substance use treatment other than to say it was “different” where she 
came from, that she felt “looked down on” there. She talked about how being able to get her 
treatment and care in the same place where she also felt no judgment facilitated honesty and 
attendance at her appointments. 
Fears for physical and emotional safety. Women shared some of the fears they 
overcame to seek treatment. Two of the women described a specific substance abuse treatment 
facility where they felt unsafe due to the mixed population and fights among the clients, further 
complicated by the refusal of the city buses to transport clients to that location. One woman 
spoke of feeling grateful that she was not referred to that facility and instead was in a practice 
where she felt safe, “‘cause that was my biggest fear of getting help.” Another woman contrasted 
her experiences between that facility and where she received substance use treatment during her 
pregnancy, a place she stated she knew was safe. Her ability to change practices was unusual as 
few treatment options for substance use disorder are available in this area, and due to limited 
capacity, it is nearly impossible to transfer to a different practice once treatment has been 
established. She talked about her fear related to interaction with the clients at the former facility; 
she described them as “enemies” and “triggers” for her. She attributed her ability to resist relapse 
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to the physical and emotional safety she felt with her current provider. In contrast, and despite 
the physical safety challenges, another woman continued treatment for her substance use 
disorder at that facility through two pregnancies. Her emotional safety seemed to outweigh any 
physical threats she felt; as she stated, “they worked around my schedule; it made it easier, and 
not one of the doctors judged me, and that absolutely helps.”  
Five women suggested that the emotional safety and trust they felt allowed them to be 
honest, which, as one woman noted, “got me better help.” Women with multiple pregnancies 
described contrasting experiences with respect to emotional safety. For example, one woman 
talked about not being honest about her substance use to providers in another state because “I 
was looked down on, I was talked about, I was treated differently, which makes you really not 
want to say anything.” During her most recent pregnancy, she stated she was honest because 
“nobody ever treated me different…even when I did slip, I did fall, I did use, I never was looked 
at weird or talked down to.” Another woman reported numerous instances of feeling judged and 
dismissed, false reports, gaps in care, and miscommunication that left her feeling mistrustful of 
her providers with both of her pregnancies (one out of state, the current pregnancy in Maine). 
She talked about wanting to stay clean and stated, “if I wasn’t thinking right I would have gone 
back to drugs because that (mistrust) was a trigger for me.” She stated she didn’t like the prenatal 
practice for those reasons but she stayed “because it was already too late for me to just go to 
another one.” Despite those experiences, she talked about being positive and not changing 
practices because “I don’t want to start all over again because I’m scared that I go back, that I 
don’t have that strength to just express myself again from the start.” She spoke most positively 
about her substance use treatment provider as she stated, “I can be open and talk to him about 
anything and trust him a lot…he’s doing a good job ‘cause I been clean for a year.” 
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Opportunities to Bond 
 This domain speaks to the women’s descriptions of aspects of care that either supported 
or inhibited opportunities to bond with their babies, themes which are also found in the maternal-
infant bonding literature. Proximity was contingent upon factors such as distance from hospital, 
physical environment, and resource availability. Women sought complete and accurate 
information to prepare for immediate newborn care and transfer home. They reported varying 
degrees of self-efficacy and participation in their baby’s care. 
Being with the baby. Twelve of the 13 women were with their babies during the 
interviews; seven of those 12 were rooming in, while space and double occupancy allowed for 
only visitation for the other five. Observed interactions with their babies varied; one woman 
breastfed her baby through the entire interview, three provided basic care (diaper change, 
swaddling), two held and rocked their babies during the interviews, and the remainder allowed 
their babies to sleep in open cribs but stopped to check on them frequently during the interviews. 
Four women indicated that their presence and active participation in their baby’s care seemed to 
alleviate their baby’s distress as exemplified by the comment, “the longer I would be away from 
him, he would start showing more agitation and irritability.” Another woman noted that her baby 
seemed to feed better for her than for the staff when she left for the night; as she stated, “when 
I’m here during the day he holds all his bottles down… he really doesn't puke besides when he's 
with them.” The woman who lived three hours away described cutting short a necessary trip 
home because her baby’s withdrawal symptoms were escalating; she believed her baby’s 
condition improved as soon as she returned and assumed care. 
Distance between home and the hospital proved to be challenging for the seven women 
from other counties. As an example, one single mother with a school-aged daughter described 
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the difficulty of being away from home for a month, stating, “I haven’t left her (her new baby), 
you know, I’ve been here for God knows how many days, 30 something days.” Three women 
expressed fear that they might have had to deliver their babies at their local hospitals, which 
were not equipped to care for substance-exposed newborns. In such cases, their newborns would 
have been transferred to the larger hospital without them. As one woman noted, “I didn't 
honestly think I was going to make it. I thought I would have to go to [small hospital closer to 
home], and you know I wouldn't be able to be with him. It was hard.” The other two women 
offered similar concerns that their babies would have been transferred without them; one stated, 
“I’m not OK with that.”  
Options allowing parent cohabitation with their babies, known as rooming-in, became 
more available with the opening of the new NICU at the large hospital. The new NICU was built 
with all private rooms, pull-out cots, private bathrooms and showers, individual breast pumps, 
and breast milk refrigerator/freezers. The five women interviewed on this unit described the 
comfort and ability to stay with their babies; three of those five women were multiparous and 
could compare the improvements with their prior experiences. In contrast, the eight women 
interviewed prior to the opening of the new NICU were limited in their ability to room in with 
their babies due to space constraints and transfer to semi-private rooms. As one woman noted, 
“it’s uncomfortable and difficult to stay here with your baby.” Another stated,  
there's no room upstairs so he had to stay here and I can't be here with him so I try to be 
here with him during the day and go home at night and sleep and, you know, which stinks 
really bad because I hate leaving him. 
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One multiparous woman was interviewed in the old continuing care nursery (lower-acuity 
intermediate care unit) just prior to the opening of the new NICU; she observed and commented 
on the construction, stating, 
Do I think that these rooms are set up to have families room in with them? No. I really 
think you guys have it right on point that their new wing or development, what they're 
doing so that it is comfortable for people to stay right there with them is the most 
important. 
Not always feeling prepared. Eight of the women described gaps in their knowledge and 
understanding of the impact of their substance use on their babies. Even women with prior 
experience seemed unprepared for their babies’ withdrawal symptoms and possible need for 
pharmacologic therapy. Women offered comments such as “nobody really prepared me for this”, 
“I didn’t know what to expect”, “they didn’t tell me how bad it could get”, and “getting that 
phone call saying we’d like to start methadone was still a shock to me.” One of those women 
said she was told that “within 5 to 7 days she’d be home and she’d be fine”; her baby required 
pharmacologic therapy and an extended hospital stay. Two women described getting information 
from friends or online searches. Only two of the eight women stated they felt well-informed and 
prepared for the required observation period and the potential for their babies to withdraw.  
 Information, education, and communication regarding newborn care seemed variable. 
Although the four first-time mothers expressed feeling well-informed and prepared for discharge 
(“they definitely go through and cover everything before they let you go home”), two of the 
women with other children were feeling ill-prepared for the challenges they were facing, such as 
how to console their child. The one woman whose baby was not present during the interview felt 
she had to send her baby to the nursery because she “didn’t know what to do with him, they’re 
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not really helping me.” Two women spoke specifically about not being informed about key 
aspects of their baby’s care, such as time and amount of prior feeding. Observations conducted in 
the inpatient care settings seemed to validate the women’s impressions. Dry erase boards 
commonly used in patient rooms for communication were noted to be blank or not updated, and 
these study interviews were frequently delayed or interrupted because the women were trying to 
track down information necessary for their baby’s care. Three women suggested that information 
was readily available if needed, although one woman felt that unless education was mandatory, 
most women would not take the time to ask. One woman stated, “whether you choose to know, if 
there’s a question you have, I pretty much feel I could ask.” Another advised health care 
providers to 
Just try to be understanding as far as the parents' concerns and their questions and try not 
to be judgmental. Um, 'cause then that makes the parents feel awkward and then they're 
not going to ask what they need to. And it's important that they can feel comfortable to be 
able to ask what they need to, 'cause otherwise they don't know what they're doing when 
they go home.   
Relationships 
The relationship domain encompasses the women’s accounts of respect, empathy, and 
inclusion (or lack thereof) as well the importance of familiarity with care providers, which 
exemplifies relational-cultural theory. They all shared examples of interactions with providers 
that exemplified respect for their choices, personal respect, understanding of how hard addiction 
and recovery are, and inclusion in decisions regarding their own care and care of their baby. This 
theme spans both prenatal care and postpartum hospital experiences.  
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Respect and judgment. Relationships with health care providers that included respect 
and understanding seemed to be most important to the women and often mitigated burdens such 
as distance and transportation. All the women manifested signs of internal stigma, referring to 
themselves as “addicts” and speaking of feeling guilt, shame, and embarrassment. As one woman 
stated about her previous experience, “people were very judgmental…that’s a big thing, you 
know, the stereotype, and you already feel shitty enough.” Despite transportation challenges, she 
continued with her current providers because none of the providers judged her; “it’s challenging, 
but we made it work.” Another woman described her challenges regarding distance, 
transportation, and substance use treatment and prenatal care in separate practices, and yet she 
persisted because of her relationships with her providers, stating, “times I thought I would 
relapse, I talked to my clinician and she’s amazing, I love her to death.” As noted by a third 
woman, “I do have the option to go somewhere closer to home, but I don’t want to, I really like 
where I am, I like the people that take care of us.” She added, “they don’t look at me and go ‘oh, 
she’s a drug addict’…this place, I’ve never felt more like a human being in my life…I matter to 
them.” Three women specifically mentioned feeling respected by the advanced practice nurse at 
the integrated care program; one woman described her as “awesome, very awesome, she’s 
fantastic”, noting that she lived 45 minutes away, “which made it a little difficult, but definitely 
worth it.” As another expressed, “it was really hard to stay clean, but there was no judgment… 
people who have been pregnant with substance abuse, everybody goes there because it’s really 
good care.” The third woman stated, “she’s made a big difference in my life…she doesn’t treat 
me like an addict.” Conversations between the principal investigator and the advanced practice 
nurse corroborated the women’s impressions; she conveyed a sense of genuine respect and 
empathy for the women for whom she cared.  
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Women in the current study anticipated judgment by caregivers, and, in many cases, their 
fears were not unfounded, as they recounted situations where they felt disrespected. One woman 
recounted “rude” behavior by a nurse caring for both her baby and the other baby in the room 
(who also had NAS), noting a contrast with how other women (whose babies did not have NAS) 
were treated. She stated, “I left a couple of times in tears.” A woman who described particularly 
traumatic prenatal and birth experiences said she was told “we don’t want to do a C-section 
because you were a junkie and we don’t want to give you drugs” even though she had been in 
recovery for over three years. She went on to say that it “made my first experience having a baby 
miserable.” She contrasted her prenatal experience with her inpatient interactions; she noted “I 
felt like people were gonna judge me because I put her here…but this place is amazing.” Another 
woman stated that “having NAS on my file and stuff, I felt not as well treated” on the labor and 
delivery unit. She described feeling “so guilty and so horrified, I felt like a horrible person, I felt 
like a horrible mother.” Two other women described similar experiences of feeling “looked 
down on” and “talked down to” because of their substance use; as one woman stated, “if I give 
respect, I should get respect back, and I don’t think nobody should talk me down, talk to me like 
I was a nobody.” She implied a willingness to endure less respectful behavior if her baby was 
well cared for, indicating that she overlooked some of the hurtful comments (“I just put my head 
down and I just walked away”). She stated several times that she was trying to focus more on the 
positive than the negative and was grateful for nurses and volunteers “taking their time to just 
care about the baby.” 
One specific NICU nurse was referred to by two women as caring and taking the time to 
talk with them; as one woman noted, “we felt very comfortable with him, he lightened the mood 
by joking, I mean, it just really raised our spirits.” During observations, this nurse seemed to take 
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an active interest in the study and spent time to converse with the principal investigator on 
several occasions, always speaking respectfully about the women. His observed interactions with 
the women were patient and kind, and the women appeared comfortable with him. This 
contrasted with other observations where staff interactions with the women seemed brief and 
limited to necessary tasks. No conclusions could be drawn from these limited observations as the 
environment did not allow for general observation of interactions with women not included in 
the study. 
Three women spoke positively about the chief pediatrician’s influence on the care they 
received. One woman described his advocacy for her to stay with her baby and relieving her 
guilt. Multiple discussions with this pediatrician by the principal investigator seemed to reinforce 
the women’s accounts. His regard for the women has been well-captured in a video documentary 
(YoungParentsLearnTogether, 2011). 
Understanding the challenges. Five women offered their opinions that providers and 
caregivers need to understand how hard addiction is and that women are doing their best to stay 
in recovery although they sometimes make mistakes. They shared that they already feel guilt and 
shame, and they asked that they not be criticized or judged, noting that such attitudes would 
discourage women from being open and honest. One woman admitted to “having slips” and 
described her prenatal providers as “understanding about everything”; as she stated, “when I did 
slip, I did fall, I did use, I never was talked down to.” Another woman attributed her ability to 
avoid relapse to the support of her provider. 
Four of the women described the challenges of having other children to care for and the 
lack of family accommodations. Two women specifically spoke to a lack of understanding about 
limitations in their presence at their baby’s bedside due to responsibilities for their other 
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children. As one woman stated, “she complained I wasn’t here early enough, she’s like ‘all I’ve 
been doing is changing his diapers all morning’…I’ve got other kids, I have to take care of them 
too.” During one observation, a nurse was heard to exclaim loudly that “she had four NAS babies 
screaming their heads off and their mothers aren’t here”, the reasons for which were not 
divulged. Conversations between the principal investigator and the two social workers revealed 
the challenges faced by the women and their impression was that it takes great courage for the 
women to overcome barriers in order to be present and care for themselves and their babies. 
Seeing different providers. One woman who was required to change practices with her 
third pregnancy expressed concern about having to establish new relationships and described her 
relief and gratitude that her previous provider facilitated transfer to a new practice that included 
familiar and trusted providers. Another woman who was also required leave a familiar practice 
upon becoming pregnant spoke of the initial adjustment and “getting used to the new providers.” 
A woman with three children who had been in recovery for over 10 years and had maintained the 
same providers recounted being “shuffled around and bounced around” initially, which made her 
feel uncomfortable due to the “stigma that comes with being an addict.” She was “pretty adamant 
that I see the same three people”, including one advanced practice nurse who “doesn’t treat me 
like I’m an addict…there’s been some trust built up and I’m open with her about things.” Two 
women described a level of discomfort with frequent changes in health care professionals both in 
their prenatal practices and in the hospital setting. As one woman noted, “having different nurses 
constantly is kind of a pain in the butt because you’ve gotta get to know someone new every 
shift.” This sentiment was echoed by another woman when she said, “each day there’s a different 
doctor, and two different nurses for each shift…that’s four nurses a day, and every one of them 
has a different way of doing things.” 
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Feeling included. Two women related specific instances where they felt included in 
decisions about their own treatment and care. As one noted, “they don’t try to pressure you into 
doing anything…they’ll sit there and talk to you, and if it’s something you don’t agree with, they 
won’t push it.” One woman noted that her substance use disorder treatment provider adjusted her 
medication doses only after discussing it with her; another woman found that her doses had been 
adjusted without her knowledge, which “kind of bothered” her. Five women described inclusion 
in choices regarding where they would deliver their babies, frequency of visits for substance use 
disorder treatment, and aspects of the baby’s care regarding medication-assisted withdrawal. 
Women described contrasting experiences in regard to feeling included in their baby’s 
care. As one woman stated: 
I definitely feel included, I definitely feel welcomed, I feel like when we're here they 
basically, you know, "do you need anything? no, OK, we're gonna let you do it". And 
that's what I want, I mean, I want the offer of help and know that it's there if we need 
them. But I also want to be a parent to my child. 
Another woman described a different impression; she spoke of feeling that her choices were not 
respected, saying, “every nurse and doctor is different…and every one of them has a way of 
doing things, and then there’s your way of doing things. I’ve tried to learn their ways…if you 
don’t, it comes back at you.” She added that “if you don't do it their way, there is a couple that, 
you know, aren't so nice.” 
Inclusion in neonatal withdrawal scoring was variable. As noted by one woman, “I’ve 
been right here with her and I do pretty much all of her care”, answering affirmatively when 
asked if she was encouraged to participate in the NAS scoring. Another woman, whose baby was 
born at a small hospital and had been transferred numerous times among three different units due 
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to acuity and space issues, recounted her attempts to participate in withdrawal scoring being 
largely ignored on several of the units. She felt this lack of inclusion contributed to at least one 
of the transfers. She noted that nurses on one of the units did take the time to listen, stating, “they 
respect me, make me feel comfortable.” A third woman wasn’t sure if her reports of her baby’s 
symptoms were considered in the scoring. 
Discussion 
 The purpose of this study was to add personal accounts to the literature regarding care of 
rural women with substance use disorders through their pregnancy and early postpartum period 
to address this gap in research. Formal interviews of the 13 rural women in this study revealed 
experiences and perceptions of the care they received during their pregnancy and through their 
infants’ hospitalization as both supportive and challenging. The women’s personal accounts were 
supported by conversations by the principal investigator with health care providers; observations 
of care environments and participant interactions with others in the context of care; and review 
of artifacts, such as publicly available information. 
 The women in this study encountered limits in access for both their substance use 
disorder treatment and pregnancy care, most notably regarding availability and insurance 
coverage for services, often having to wait to get treatment. While these challenges may not be 
unique to rural women, they are intensified by the lack of capacity related to too few willing 
and/or knowledgeable providers in rural areas (Bishop et al., 2017; Rosenblatt, Andrilla, Catlin, 
& Larson, 2015). This was demonstrated by the women’s descriptions of having to travel long 
distances using sometimes unreliable transportation to access services or encountering perceived 
knowledge deficits in their local care providers. These women all relied on public assistance for 
their health care; specialty services for substance use disorders have been found to be more 
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heavily financed by public sources, such as Medicaid (Cummings, Wen, Ko, & Druss, 2014). 
The state where this study was conducted is one of the 19 states that did not expand Medicaid 
coverage to low-income adults, which directly impacted three of the women in this study as they 
described the long wait for treatment for their substance use disorder until they became pregnant. 
Public assistance also impacts transportation options for these women. These challenges have 
been outlined in numerous articles in the major local news media over the past six years as 
funding has been cut and restrictions placed on eligibility and treatment duration (Appendix F).  
In general, the women described gaps in information and their understanding of available 
resources and the impact of their substance use on their babies. Paired with this lack of 
information were variable degrees of inclusion in decision-making and the care of their 
newborns. Women in a study conducted by Howard (2016) likewise noted a wide range of 
information and inclusion with respect to their options. Evidence exists that maternal presence 
and active involvement in decision-making and care result in improved maternal and newborn 
outcomes (American Academy of Pediatrics [AAP], 2016; Boucher, 2016; Edwards & Brown, 
2016; Holmes et al., 2016; McKnight et al., 2016). Six of the babies in this study required 
pharmacologic therapy for NAS; three were deemed eligible for earlier discharge home on a 
methadone weaning protocol, as opposed to a traditional inpatient methadone wean. The 
woman’s active involvement in her baby’s care, with support from a multidisciplinary team, is 
required for this outpatient treatment. 
 The women’s experiences and interpretations of how they were perceived by both 
outpatient and inpatient care providers seemed to dominate the interviews. The women revealed 
a willingness to accept inconvenience and logistical challenges to receive care where they felt 
respected and understood. As noted by Marcellus and Poag (2016), these women “typically face 
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significant negative attitudes, judgment, and stigma” (p. 327). Additionally, women chose to 
travel longer distances from their homes to access treatment and care by providers they perceived 
as more competent. Oser and Harp (2015) suggested that while stigma and rural cultural values 
may inhibit utilization of substance abuse treatment and support resources, rural clients with 
SUD may prefer treatment in a more urban setting for the perceived practice expertise, relative 
obscurity, and reduced stigma. They used the term geographic discordance to describe the 
phenomenon of “traveling from one’s home residence to a county with a different socio-cultural 
context” to receive treatment and care (Oser & Harp, 2015, p. 77).  
The women in the present study expressed feelings of guilt, shame, and embarrassment, 
particularly when they talked about the effect of their substance use on their babies and the rest 
of their families. Similar feelings were described by women in a recent study conducted by 
Cleveland, Bonugli, and McGlothen (2016). In that study, as in the present study, the women felt 
their presence and active participation in their baby’s care alleviated their baby’s distress. 
Findings of new research suggests that newborns whose parents spent more time at their bedside 
have less severe withdrawal symptoms and shorter hospital stays during treatment for NAS 
(AAP, 2016). Women in the present study expressed fear of being judged by health care 
providers based on their prior experiences or those of their acquaintances. Such fear and stigma 
have been shown to be barriers to treatment and care, discouraging women from seeking and 
engaging in substance use treatment and prenatal care, potentially increasing the risk of harm to 
the mother and baby (CSAT, 2009; Stone, 2015). Judgment of pregnant women with SUD by 
rural practitioners due to a lack of knowledge and experience regarding perinatal substance use 
may be reduced through targeted education (Seybold et al., 2014).  
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The personal accounts shared by the women were consistent with concepts gleaned from 
the harm reduction, maternal-infant bonding, and relational-cultural literature. The women 
touched upon elements of harm reduction strategies, including information and understanding of 
available resources, access to services, collaboration among providers, transportation assistance, 
and integrated care models, as they related both supportive and challenging care experiences. As 
noted, 12 of the 13 women were with their babies during the interviews, whether they could 
room in or not. They spoke of some of the challenges they encountered to be with their babies 
and their belief that their involvement in their baby’s care was important. A qualitative study 
conducted by Atwood et al. (2016) revealed similar themes, such as parental education and 
preparation for NAS, parents as partners in care, interpersonal interactions and communication 
with the health care team, and the hospital environment and transitions in care. The women 
interviewed in the present study conveyed a need for connection, a basic tenet of relational-
cultural theory, whether that be with providers and caregivers, other women in similar 
circumstances, or their babies and other family members. They all expressed gratitude for the 
opportunity to tell their stories and hoped the information they shared would be helpful to others. 
They were emotional and often shed tears when they related episodes that seemed painful to 
them. They wanted people to understand that addiction and recovery were hard; they were doing 
their best despite the barriers; they took responsibility for their choices; sometimes other 
responsibilities kept them from being with their babies; and judgment and disrespect were 
triggers to relapse that also discouraged them from being honest. Five of the women had 
diagnosed mental health disorders, including post-traumatic stress disorder; six others described 
traumatic events that they felt contributed to their substance use disorders and relapses. Research 
has shown that interactions not grounded in respect and empathy can retraumatize women, 
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triggering relapse and impeding access to care (Boyd & Marcellus, 2007; Covington, 2008; 
SAMHSA, 2014b).  
Implications 
The results of this study add the voices of rural women in the development of practices 
and policies regarding access to substance use treatment, care provider education and training, 
non-punitive approaches to substance use during pregnancy, and models of both prenatal and 
postpartum care of the mother-infant dyad. As the rates of perinatal substance use disorders and 
NAS continue to rise, nurses, other health care providers, and social and mental health 
professionals need to be mindful of the unique challenges and complex needs of this population, 
particularly in rural areas where services are limited. Legislation, such as the Drug Addiction 
Treatment Act of 2000 (DATA2000), the Office of National Drug Control Policy 
Reauthorization Act of 2006, the 2010 Affordable Care Act (ACA), and the 2016 
Comprehensive Addiction and Recovery Act (CARA), has expanded substance use treatment 
options that may benefit areas with limited substance use treatment providers. Office-based 
physicians who have completed approved courses or have board certification in addiction 
medicine (called “waivered physicians”) may prescribe buprenorphine maintenance therapy, 
with patient limits recently increased from 30 to 100 per waivered physician (DeFlavio, Rolin, 
Nordstrom, & Kazal, 2015; Stein et al., 2015). Section 303 of CARA extended buprenorphine 
prescribing privileges to nurse practitioners and physician assistants who have completed 24 
hours of required training, thereby increasing the number of providers and filling practice gaps in 
rural areas (ASAM, 2017). Despite this expansion, providers have cited inadequate training as 
the biggest barrier to adoption (DeFlavio et al., 2015). Learning collaboratives, utilizing 
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teleconferencing across a wide rural geographic area, may provide a solution to that challenge 
(Nordstrom et al., 2016).  
While availability, accessibility, and affordability may impede substance use treatment in 
rural areas, acceptability related to guilt, shame, and fear of stigma has been found to be a greater 
barrier (Jackson & Shannon, 2012). The women in the present study demonstrated a willingness 
to sacrifice convenience of services closer to home for substance use treatment and prenatal care 
that was felt to be respectful and inclusive. Compassionate, women-centered approaches that 
incorporate a harm reduction philosophy are key to successful care of these women (Sutter, 
Gopman, & Leeman, 2017). The CSAT (2009) and other agencies (SAMHSA, 2016; WHO, 
2014) have identified strategies to engage women with substance use disorders through 
development of personal connections and trusting relationships. Additionally, several published 
local, national, and international guidelines encourage parent education, anticipatory guidance, 
and collaborative decision-making to improve care and outcomes for the mother-infant dyad 
(Maine Chapter AAP, n.d.; O’Connor & Alto, n.d.; SAMHSA, 2016; WHO, 2014). Further, 
programs for outpatient pharmacologic therapy for newborns withdrawing from opioid exposure 
are showing promising outcomes with respect to length of stay and expenditures (Lee, Hulman, 
Musci, & Stang, 2015); such a program has been available since 2014 in the area where the 
current study was conducted, and three of the women’s babies were being discharged home 
through this program.  
More research is needed to explore the uptake of the new SAMHSA (2016) guidelines 
and their subsequent effects on maternal and infant outcomes. Women in the present study, 
particularly the six who received their substance use treatment and prenatal care through separate 
practices, described their experiences of provider practices and interactions that were 
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inconsistent with recommendations of the SAMHSA guidelines, such as lack of collaboration 
and standardization of care. The comprehensive guideline promotes collaborative policies and 
practices to “support the health, safety, well-being, and recovery of pregnant women with opioid 
use disorders and their infants” (SAMHSA, 2016, p. 8), focusing on interventions that may 
reduce the harm of perinatal substance use. The nurse’s role in the care of the woman and her 
newborn in outpatient, acute care, and community-based settings is delineated in the guidelines. 
Nursing research should focus on the most effective strategies in overcoming the well-
documented barriers to substance use treatment and prenatal care in rural areas, such as lack of 
resources. The women in this study offered their perspective on their unique challenges as well 
as suggestions for mitigating those barriers, specifically in regard to collaboration, 
communication, and relationships. Further studies are essential to identify effective care delivery 
models and best practices for staff training regarding perinatal substance use and care that is 
nonjudgmental, standardized, and collaborative. Longitudinal studies would provide evidence of 
factors that contribute to engagement in treatment and care, sustained recovery, and child 
development. Research into the impact of changing public policy on women’s access to 
treatment and care is also necessary. 
Knowledge translation, defined as a “dynamic and iterative process that includes the 
synthesis, dissemination, exchange and ethically sound application of knowledge to improve 
health, provide more effective health services and products and strengthen the healthcare 
system” (Straus, Tetroe, & Graham, 2011, pp. 6-7), provides a framework to support 
improvement of care based on the research findings. The Rural Health Research Gateway 
(https://www.ruralhealthresearch.org/), an online library of research and expertise supported by 
the Federal Office of Rural Health Policy, Health Resources and Services Administration, U.S. 
  150 
Department of Health and Human Services, includes a toolkit for dissemination of rural health 
research (Schroeder, 2015). The toolkit proposes guidelines for various modes of dissemination 
and provides examples of effective use of products (e.g., policy briefs, fact sheets, publications, 
and presentations) through social media, press releases, and media interviews. As noted by 
Boydell, Stasiulis, Barwick, Greenberg, and Pong (2008), it is important that dissemination 
strategies are adapted to the audience and specific community. This toolkit can be a valuable 
resource for moving the findings of the present study into practice. 
Study Limitations 
Recruitment in this population was found to be challenging with respect to ethical 
approval, participant eligibility and availability, practice changes, and discrepancies in the 
recruitment process. To conduct this study, ethical approval from two Institutional Review 
Boards (IRBs) was required, a process that involved two full board reviews and took nearly eight 
months. Recruitment procedures seemed inconsistent for unclear reasons, and potential 
participants were found to be ineligible or unavailable in nine of the 22 referrals. Despite several 
amendments to the research protocol and expansion of recruitment methods and locations, 
participant recruitment was limited to the tertiary care hospital and two local perinatal practices. 
No participants were recruited for the present study from the rural county where community-
based services are coordinated to compensate for the lack of an integrated care model. Early 
successes of the program, such as increased prenatal care visits and decreased hospital length of 
stay for babies with NAS, have been reported (Morton, Withers, Konrad, Buterbaugh, & Spence, 
2015), and the local hospital also expanded care for infants with NAS, both of which may have 
accounted for the lack of participants from that county. 
  151 
Visits and frequent telephone and e-mail contact with key personnel by the principal 
investigator did not seem to increase the potential participant pool. Conversations with outpatient 
providers and inpatient social workers revealed potential challenges to recruitment, including the 
women feeling overwhelmed with information about programs and services, multiple other 
studies being conducted in this population, and women often not being present due to 
transportation and/or other family obligations. Staff conceded that they often forgot to introduce 
the study to eligible women due to workload issues, indicating that a number of potential 
participants were likely missed.  
Opportunities for substantial observation periods were limited due to hospital renovation 
and new construction. The units lacked common public areas and family waiting rooms, and 
prior to the opening of the new NICU, many patient rooms were semi-private. Hospital staff 
requested that the principal investigator not linger in hallways or outside patient rooms to respect 
the privacy of other families, so opportunities for observation of the general care environment 
were confined to the nurses’ stations or chart rooms during collection of demographic data. 
Additionally, as anticipated, the women were often fatigued, entertaining visitors, or had other 
commitments that shortened the interviews and observations.  
Data collection was limited to the inpatient setting, and therefore the women’s accounts 
of their prenatal experiences were retrieved from memory and may have been influenced by their 
current postpartum experience. Although women were given the researcher’s contact 
information, and ten of the 13 women consented to follow-up, only one woman responded to the 
member checking letter. Sequential interviews and observations over time, to include the 
prenatal and post-discharge period, may have contributed valuable insights into the women’s 
experiences.  
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Selection bias may have been present due to the vulnerability of this population. Women 
who consented to participate in this study either retained full custody of their newborns, had 
relinquished custody to a family member, or were working on reunification. All participants 
were aware of the state mandated reporting to the Department of Health and Human Services of 
infants identified as being prenatally substance exposed (Child and Family Services and 
Protection Act, 2003). Women who did not volunteer for participation in the study may have 
feared child protective services investigation; therefore, results of the present study may not 
represent the views of such women. 
Conclusions 
 Substance misuse persists, and pregnant and parenting women with substance use 
disorders continue to face stigma and barriers to treatment and care despite the mounting 
evidence that addiction is a chronic relapsing medical condition (Terplan et al., 2015). Nursing is 
the largest of the health care professions in the U.S., and nurses comprise the largest single 
component of hospital staff (American Association of Colleges of Nursing [AACN], 2011). 
Nurses’ scope of practice includes comprehensive assessment, collaboration with other members 
of the health care team, development of patient-centered health care plans, and evaluation of 
nursing interventions, all important components of care for women with substance use disorder 
and their babies (Russell, 2012). Nurses connect with women in both community-based and 
inpatient settings and, as such, can positively impact the care of these women and their babies 
through provision of skilled, nonjudgmental care (Chu & Galang, 2013; McKeever, Spaeth-
Brayton, & Sheerin, 2014; Shaw et al., 2016). Evidence and resources are available to provide 
compassionate care. It is imperative that nurses become actively involved in development of 
public policies to support collaborative, integrated models of care, reduce rural and poverty-
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related health disparities, and discourage punitive treatment of women that only serves to impede 
their access to treatment and care.  
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Table 1: Demographic characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic Definition n = 13 
Age Years 
29 
(range 22-40) 
Race 
White 11 
Black 1 
Latina 1 
County 
Pen….. 6 
Pisc……. 2 
W…. 2 
A…….. 1 
H…… 1 
O….. 1 
Marital 
status1 
Married 2 
Partner 7 
Single 4 
Child 
custody2 
Full 9 
Visitation 1 
Relinquished 1 
Unclear 2 
Pregnancy 
Primiparous 4 
Multiparous 9 
Delivery 
SVD - term 6 
SVD - preterm 1 
Unplanned home delivery 2 
Induced (IUGR) 2 
Planned repeat CS 2 
NAS Rx 
None 4 
Pharmacologic (inpatient) 5 
Pharmacologic (outpatient) 2 
Uncertain (still under observation) 2 
Stage of 
recovery3 
Adherent 6 
Relapsing 6 
Court-ordered residential treatment 1 
Location in 
hospital 
NICU (old) 2 
NICU (new) 5 
CCN 3 
MBU 2 
Pediatrics 1 (external transfer) 
Prenatal Care 
FMRP 7 
WCHM 4 
W…. County 1 
A…….. County 1 
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Table 1 Legend: 
1. Marital status: 
a. Partner: women referring to a partner, boyfriend, or fiancé; Maine does not have 
common law marriage 
b. Single: women stating they were single or divorced and not with the father of the 
baby 
2. Child custody: 
a. Visitation: previous child in relative care with visitation rights 
b. Relinquished: Previous children had been relinquished to child protective 
services, working on reunification 
c. Unclear: Custody of previous children relinquished to their fathers, custody status 
of current baby undetermined/undocumented  
3. Stage of recovery: 
a. Adherent: Evidence of consistent use of medication-assisted therapy (methadone 
or buprenorphine) in narrative documentation and toxicology screening  
b. Relapsing: Evidence of use of illicit substances in addition to medication-assisted 
therapy (methadone or buprenorphine) in narrative documentation and toxicology 
screening 
4. Definitions of acronyms: 
a. SVD: spontaneous vaginal delivery 
b. IUGR: intrauterine growth retardation 
c. CS: Cesarean section 
d. NICU: neonatal intensive care unit 
e. CCN: continuing care nursery 
f. MBU: postpartum mother-baby unit 
g. FMRP: integrated care program where specialized substance use disorder 
treatment, mental health, and social services are co-located within a perinatal care 
practice 
h. WCHM: prenatal practice that does not include specialized substance use disorder 
treatment, mental health, and social services 
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Appendix G: Data Analysis Process Flowchart 
 
Familiarization
• Listened to recorded interviews for elements of speech
• Transcription of recorded data & fieldnotes
• Reviewed all transcribed data
• Reviewed artifacts
• Initial random coding
Thematic 
framework
•Theoretical constructs extracted from literature
•Pre-fieldwork information considered
Indexing
•Coding themes created
•Transcribed & artifact data color-coded, placed within 
themes 
•Annotations & analytic memos
Charting
•Matrices developed for data retrieved from interview 
transcripts, observational notes, & artifacts
•Verbatim text abstracted, synthesized, & summarized
Mapping & 
interpreting
•Data matrices reviewed for themes & patterns
•Generated possible explanations, influenced by study aims
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